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Abstract 
Schistosomiasis is a major public health problem in many developing countries. The disease is 
endemic in 74 countries and infects nearly 250 million people worldwide. Among the five main 
species affecting humans, Schistosoma mansoni and S. japonicum are responsible for the majority of 
hepato-intestinal schistosomiasis. Praziquantel is the only available drug against this chronic 
debilitating disease and many vaccines are being trialled in the search for an effective control of the 
disease. 
Adult schistosomes are dependent on the blood of their definitive host for nutrition. In the process of 
ingesting and breaking down host erythrocytes, large quantities of haem are released. Despite being 
a potentially toxic molecule, haem is an essential factor for numerous biological reactions and may 
also serve as an important source of iron. The molecules involved in the catabolism of red blood cells 
(RBC) and release of its end-product haem, are potential targets for development of anthelmintic 
drugs or vaccines. By contrast, knowledge on haem metabolism and the associated uptake in 
schistosomes is limited and further research may identify potential targets among the molecules 
involved in haemoglobin breakdown and haem utilization or sequestration.  
In the first part of this thesis, the de novo haem biosynthetic capability of schistosomes was 
determined by investigating two enzymes of the eight-enzyme haem biosynthetic pathway, δ-
aminolevulinic acid dehydratase (ALAD) and ferrochelatase (FC).  The function of the two enzymes 
was investigated using a combination of three techniques: (1) in silico analysis of protein sequences; 
(2) complementation assays using mutant E. coli strains defective in haem biosynthesis; (3) enzymatic 
assays using the recombinant schistosome proteins. While the in silico analysis suggested that these 
proteins are likely to be active enzymes, complementation and enzymatic assays were unable to verify 
their function.  
In the second part of the thesis, it was hypothesized that an adaptive haem uptake mechanism is 
present in the schistosomes to support their haem needs. This hypothesis was confirmed with a pulse-
chase experiment using a fluorescent haem analogue, palladium mesoporphyrin IX (Pd-mP). The 
results of this experiment indicated that the transmembrane uptake of haem in schistosomes is likely 
to be an active process that is specific to haem. Further, it was demonstrated that Pd-mP is taken up 
and accumulated in the vitellaria and ovary of females, suggesting that haem uptake and metabolism 
is an essential biological process that supports reproduction in schistosomes. Further investigation of 
the underlying mediating this transmembrane transport of haem was presented by targeting this 
pathway pharmacologically.  
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It was demonstrated that cyclosporin A (CsA) inhibits the uptake of Pd-mP, a fluorescent haem 
analogue, by the ovary of S. mansoni in concentration-dependent manner. Furthermore, it was shown 
that worms treated with CsA had significant reduction in egg production and the eggs produced by 
the treated worms showed delays in development and maturation. This suggested that the anti-
fecundity effect of CsA on schistosomes is related to the inhibitory effect of CsA on haem uptake in 
the parasites.  
A putative haem transporter protein, S. mansoni haem responsive gene-1 (SmHRG-1), was identified 
based on loose sequence homology with the C. elegans haem transporter protein, HRG-4. In the 
knock-down study, it was found that worms treated with Smhrg-1 dsRNA had significant decrease 
in egg production and maturation of the laid eggs. This result implied that SmHRG-1 could be 
involved in embryogenesis and vitellogenesis. The functionality of SmHRG-1 as a transmmembrane 
haem transporter was confirmed by complementation assays using a mutant yeast strain in both liquid 
and solid media.  
Overall, my thesis suggest that SmHRG-1 is a potential haem transporter protein in S. mansoni and 
this uptake of haem is required in the egg production and may affect subsequent maturation of the 
eggs. It was concluded that SmHRG-1 may represent a promising target for drug and vaccine 
development in the control of schistosomiasis, given its involvement in egg production and 
subsequent maturation of egg.  
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Chapter 1 – Introduction 
1.1 Background 
Schistosomiasis is a water-borne disease caused by parasitic trematodes of the genus Schistosoma. 
Three species, namely Schistosoma mansoni, S. japonicum and S. haematobium, are responsible for 
most of the human cases (King et al., 2005; Sturrock, 1993). Schistosomiasis is one of the most 
prevalent parasitic infections worldwide and is endemic in 74 developing countries, affecting over 
200 million people (King et al., 2005). In addition, over 650 million people are at risk of infection 
(Steinmann et al., 2006). For schistosomiasis, it is estimated that approximately 10% of infected 
individuals suffer serious complications of this disease (van der Werf et al., 2002). It is estimated that 
schistosomiasis accounts for approximately 280,000 deaths per annum in sub-Saharan Africa alone, 
where ~80% of world-wide cases occur (van der Werf et al., 2002). However, this figure is likely to 
be an underestimate, given the limitations of available data, particularly the lack of standardization 
in data collection in studies carried out in sub-Saharan Africa (King et al., 2005; van der Werf et al., 
2002). In view of the high prevalence and chronic nature of this disease, schistosomiasis represents a 
serious public health burden (Hotez, 2009). 
As an insidious chronic disease, schistosomiasis causes severe morbidity, resulting in significant loss 
of physical performance (Engels et al., 2002; van der Werf et al., 2002). In addition, it has been 
shown the disease is associated with infertility (Swai et al., 2006), increased risk of cancer (Schwartz, 
1981), and increased susceptibility to infectious diseases such as hepatitis C and AIDS/HIV (Secor, 
2005). Besides causing symptoms like haematuria, anaemia and malnutrition, schistosomiasis 
adversely affects cognitive development and learning ability and causes growth stunting in children 
(King and Dangerfield-Cha, 2008). School-age children are at greatest risk from schistosomiasis-
related morbidity, with many studies demonstrating the highest prevalence and intensity of infection 
within this age group (Kabatereine et al., 1999; King et al., 1992). Although effective treatment is 
available, the greatest impact on reducing morbidity is only achievable when treatment is given in the 
early stages of infection (Gryseels, 1989). Clearly, the detrimental impact of schistosomiasis on a 
population is more than just the accumulated morbidity and mortality count, and early treatment is 
essential to prevent the serious sequelae of this disease  (King and Dangerfield-Cha, 2008).  
The drug of choice, praziquantel (PQZ), is a safe, cheap and effective drug that is used to treat all 
forms of schistosomiasis (Engels et al., 2002; Smits, 2009). However, this drug has a major limitation 
in that juvenile schistosome worms are not susceptible to PQZ action (Cioli and Pica-Mattoccia, 2003; 
Xiao et al., 1985). This deficiency is especially important in areas with high transmission rates, where 
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a two-dose treatment is required to obtain significant reduction in infection (Doenhoff et al., 2008; 
Utzinger et al., 2000). The widespread availability and usage of PQZ has led to fears of resistance 
and tolerance to the drug (Hotez, 2009). This has been backed by reports of low cure rates in Egypt, 
Senegal and Kenya in the field (Botros et al., 2005; Danso-Appiah and De Vlas, 2002; Melman et 
al., 2009), coupled with experimental evidence demonstrating decreased susceptibility and possibly 
resistance of the parasite to PQZ  (Coles et al., 2001; Ismail et al., 1999). Although alternatives to 
PQZ are available, problems of varying efficacy against the different strain and toxicity limit their 
use (Thetiot-Laurent et al., 2013). Undoubtedly, the need for alternatives to PQZ is pressing.  
Haem is a pro-oxidant molecule that is essential for many metabolic processes (Ponka, 1999). The 
importance of haem for schistosomes is emphasised by the demonstrated presence of numerous 
haemoproteins, like cytochrome b and cytochrome oxidas (Coles, 1973; Glanfield et al., 2010; Liu et 
al., 2006; Saeed et al., 2002). As with all blood-feeders, schistosomes release large quantities of haem 
after digesting and catabolising host erythrocytes.  Schistosomes convert haem into haemozoin (Hz), 
an inert crystalline molecule, which nullifies its potential toxicity (Oliveira et al., 2000a). However, 
ingested haem molecules serves as a possible source of iron (Fe) for these parasites and it is plausible 
that schistosomes are able to salvage and recycle host haem to complement its endogenous production 
of proteins that require haem or iron as co-factor. It remains uncertain as to whether schistosomes 
synthesize haem, salvage host haem or utilize a combination of these mechanisms to support their 
haem needs. Understanding these haem metabolic processes in schistosomes could represent an 
important metabolic pathway needed for parasitism and survival within the human host, and provide 
potential drug targets. This project aims to understand the haem metabolic pathway in schistosomes 
by investigating haem biosynthesis and uptake systems in this parasite. 
1.2  Life cycle 
Schistosomes have a complex life-cycle that involves a definitive mammalian host, an intermediate 
snail host, and free-living infective stages (Allan et al., 2009; Sturrock, 1993). The geographical 
distribution of each schistosome species is linked to that of the specific intermediate snail hosts 
(Sturrock, 1993). Through water-related activities, like swimming, fishing and washing clothes, in 
water bodies containing the infectious cercarial stage, humans come into contact with the free-
swimming larvae  (Steinmann et al., 2006; Sturrock, 1993). Following contact, the larvae penetrate 
into human skin and cause infection (Allan et al., 2009). Major features of the life cycle are presented 
in Figure 1.1.  
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1.3  Pathogenesis 
Three distinct syndromes can result during the course of schistosome infection: cercarial dermatitis, 
and acute and chronic schistosomiasis (Lambertucci, 1993; Pearce and MacDonald, 2002). Cercarial 
dermatitis and acute schistosomiasis are short-term conditions that usually resolve without treatment 
 
Figure 1.1. Life-cycle of schistosomes (Image take from Centers for Disease Control and 
Prevention: http://www.cdc.gov/parasites/schistosomiasis/biology.html). Adult schistosomes, which 
inhabit the mesenteric venules of the small intestines (for S. mansoni and S. japonicum) or the 
venous plexus of the bladder (for S. haematobium) of the vertebrate host, lay eggs in the blood 
vessels. The eggs penetrate the vessel walls and are excreted to the external environment via faeces 
or urine. In fresh water, miracidia hatch from eggs and seek and penetrate an intermediate snail host. 
Within the hepatopancreas of the snail, the miracidium transforms into a mother sporocyst. Each 
mother sporocyst asexually produces successive generations of daughter sporocysts, which give rise 
to asexual reproduction to cercariae. These cercariae will subsequently break out of the snail tissue 
before seeking and penetrating the skin of the vertebrate host, transforming into schistosomula with 
the shedding of their forked tail. Schistosomula migrate through several tissues until residing in the 
liver, where they sexually differentiate into mature adults. The cycle is completed with the pairing 
of young adults, which will migrate against the blood flow of the hepatic portal system to the 
mesenteric or vesical veins, depending on the species of the schistosome.  
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(Lambertucci, 1993). Depending on the species involved and the site in which the adults reside, 
chronic schistosomiasis can result in hepato-intestinal or urinary schistosomiasis (Pearce and 
MacDonald, 2002). The symptoms of intestinal schistosomiasis are intermittent bloody diarrhoea, 
colonic polyposis and anaemia (Pearce and MacDonald, 2002; Secor, 2005). Complications include 
portal hypertension, hepatic fibrosis and haematemesis  (van der Werf et al., 2002). Urinary 
schistosomiasis results in haematuria and urogenital disease. Complications are obstructive uropathy, 
kidney failure and cancer of the bladder (Schwartz, 1981; van der Werf et al., 2002). 
The main pathogical effects of chronic schistosomiasis are due to the accumulation of schistosome 
eggs that lodge in various tissues and organs and to the resulting host immune reactions against these 
eggs.  These responses consist of granulocytic cellular responses (the granulomata) that give rise to 
fibrous tissue around tissue-trapped eggs (Pearce and MacDonald, 2002). The scarring, in turn, results 
in structural organ damage and vessel blockage (King and Dangerfield-Cha, 2008). Disease 
development is largely dependent on the host immune response and the intensity of infection (Pearce 
and MacDonald, 2002; Secor, 2005). Co-infection of schistosomiasis with other diseases (e.g. 
tuberculosis and HIV) is postulated to result in greater levels of morbidity and mortality  (Karp and 
Auwaerter, 2007; Secor, 2005). However, evidence provided thus far is inconclusive in supporting 
this association (Secor, 2005).  
1.4  Blood feeding 
Host erythrocytes play a pivotal role in parasitism of haematophagous endoparasites, like 
schistosomes and malaria. While the red blood cells (RBCs) and other blood components provide 
essential nutrients, blood vessel of their vertebrate host is an equally hostile microenvironment for 
these parasites (Korner et al., 2010; McMorran et al., 2009; Whitfield, 1979). 
Adult schistosomes feed on red blood cells (RBCs) and other blood components to obtain the essential 
nutrients and amino acids required for parasite development, growth and reproduction (Brindley et 
al., 1997; Lawrence, 1973). Blood feeding in schistosomes begins 3-5 days post-cercarial infection 
(Brindley et al., 1997; Lawrence, 1973). Paired adults process about 330,000 cells/hour and require 
about four hours to completely exchange the caecal content (Lawrence, 1973). Females have higher 
nutrient requirements and ingest up to 0.88 μL of blood per day  (Lawrence, 1973). Females can 
ingest up to 13 times as many RBCs as their male partners, are nine times faster in the ingestion of 
RBC, and require less than one hour to completely exchange content of their caeca (Lawrence, 1973).  
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1.4.1  Enzymatic breakdown of RBCs  
Following ingestion by schistosomes, RBCs are lysed within the gastrodermis, releasing haemoglobin 
(Hb) (Brindley et al., 1997). Two expressed sequence tags (ESTs) of a saposin-like protein (SAPLIP), 
Sm-slp-1 and Sm-slp-2, have been identified in the gastrodermis of S. mansoni (Don et al., 2008). 
Members of the SAPLIPs family are lipid-targeting proteins involved in the disruption of membrane 
structure (Bruhn, 2005).  Thus, it is suggested that Sm-SLP-1 could function as a RBC hemolysin in 
S. mansoni (Don et al., 2008). 
Subsequent breakdown of Hb is a complex pathway postulated to involve several key gastrodermis-
associated proteases, including cathepsins B, L, D and asparaginyl endopeptidase. These enzymes 
have been suggested to share substrate specificity to ensure efficient Hb catabolism (Brindley et al., 
1997; Delcroix et al., 2006). This process releases dipeptides and free amino acids required for 
parasite growth and reproduction (Brindley et al., 1997). At the same time, large quantities of haem 
are generated.  
1.5  Iron as an essential trace element  
Fe is an essential trace element required for many biological reactions and serves as a critical co-
factor required for the activity of many biologically important proteins (Glanfield et al., 2007). Due 
to the importance of Fe for microbes, creating an iron-restricted environment in the host is one of the 
many strategies utilized in innate immunity against infection (Glanfield et al., 2007). Iron uptake 
systems in prokaryotes have been studied extensively and include strategies such as the use of 
siderophores to bind ferric iron and the use of receptors or proteins to bind and take up host iron 
carriers such as transferrin  (Koster, 2001).  
1.5.1  Iron uptake and storage in schistosomes  
Fe is essential for the development and reproduction of schistosomes (Glanfield et al., 2007). 
Furthermore, it is postulated to play an important role in quinone-tanning of eggshell in which 
dihydroxyphenylalanine (DOPA)-quinone crosslinks with adjacent proteins and form a hardened 
structure that protects the eggs from host hydrolytic enzymes (Jones et al., 2007). Thus, the ability of 
schistosomes to utilize Fe from the host can be a critical factor in the successful establishment of 
infection (Glanfield et al., 2007). So far, all evidence regarding iron uptake by schistosome points to 
surface-mediated (tegumental) pathways (Clemens and Basch, 1989), but the possibility of a 
gastrodermis-specific pathway cannot be discounted.  
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In schistosomes, uptake of surface-linked iron may occur in a transferrin-dependent or -independent 
manner (Clemens and Basch, 1989). Schistosomes can bind transferrin at their surface in a non-
saturable manner that lacks specificity (Clemens and Basch, 1989), however, the mediator of this 
transferrin-dependent pathway remains unknown (Clemens and Basch, 1989; Smyth et al., 2006). 
Transferrin-independent mechanisms may involve a family of divalent metal transporters (DMT1) 
(Glanfield et al., 2007; Smyth et al., 2006). For S. mansoni, two DMT1 isoforms, termed SmDMT1-
A and -B, have been identified, and were shown to be expressed in the tegument and parenchyma, 
but not in the gastrodermis as anticipated (Glanfield et al., 2007; Smyth et al., 2006). Schistosome 
DMT1s are functional transmembrane iron transporters as demonstrated by their ability to rescue 
ferrous iron-transport deficient yeast grown in media with low iron concentrations (Smyth et al., 
2006). These two molecules show different patterns of stage-associated expression, despite sharing 
highly similar amino acid sequences, with sequence variation occurring only in the N-terminal 
regions of the proteins (Smyth et al., 2006). However, there remains a gap in knowledge on the exact 
mechanisms used by schistosomes to salvage iron from the host (Glanfield et al., 2007; Smyth et al., 
2006). 
Two isoforms of the cytoplasmic Fe-storage proteins called ferritins (schistosome Fer1 and Fer2) are 
expressed in adult schistosomes (Dietzel et al., 1992). Both schistosome molecules share substantial 
sequence identity with heavy (H) chain ferritin of mammals (Dietzel et al., 1992). Fer1, or yolk 
ferritin, is expressed mainly in the vitelline cells (egg-shell precursor cells) of adult females and at 
almost undetectable levels in adult male worms (Dietzel et al., 1992; Jones et al., 2007). This 
molecule is highly expressed in the vitelline cells of females indicating that it is an essential 
component in oogenesis and embryogenesis (Jones et al., 2007). Fer2, or somal ferritin, is detected 
in both male and female adult worms as well as in eggs (Dietzel et al., 1992; Jones et al., 2007). 
Expression of Fer2 is greatest in adult males, followed by female adult worms and finally in eggs 
(Jones et al., 2007). 
1.5.2  Haem as an important iron source 
In humans, dietary haem is an essential source of iron that contributes significantly to iron absorption 
(Carpenter and Mahoney, 1992; West and Oates, 2008b). The importance of dietary haem has been 
attributed to (1) the high bioavailability of haem in an alkaline environment, (2) the presence of 
proteins increasing the solubility of haem and (3) the absence of inhibitory factors affecting 
absorption of haem in the lumen of the small intestine (Carpenter and Mahoney, 1992; West and 
Oates, 2008b).  The subsequent breakdown of haem is postulated to be catalysed by the enzyme haem 
oxygenase 1 (West and Oates, 2008a). The catabolism of haem releases Fe, contributing to the labile 
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iron pool (West and Oates, 2008b). However, there are still gaps in the understanding of the exact 
mechanism underlying the uptake, breakdown and finally, transport and storage of this haem-iron 
(West and Oates, 2008b). 
In blood-feeding parasites, haematophagy creates a unique environment that provides an abundance 
of iron and haem. Iron-containing haem makes up the majority of the total intracellular iron pool in 
humans, with haemoglobin alone accounting for greater than 60% of the iron pool (Carpenter and 
Mahoney, 1992; Walsh et al., 1955). Thus, host haem is undeniably a potentially important source of 
iron in these haematophagous parasites, possibly contributing to the majority of the iron needs. A 
study investigating the fate of a blood meal iron in Aedes aegypti supports this postulate (Zhou et al., 
2007). This study demonstrated that although most of ingested host transferrin (~92%) is absorbed in 
A. aegypti, the majority of the iron (>97%) retained in the body and eggs originates from haem-iron 
(Zhou et al., 2007). The study also indicates that only 13% of exogenous haem is absorbed despite 
showing that haem-iron accounts for most of the iron retained in A. aegypti (Zhou et al., 2007).  
Although uptake of transferrin-iron has been demonstrated for schistosomes, there are no available 
data on the distribution of transferrin-iron and haem-iron in the parasites. Thus, the iron absorption 
profile in schistosomes may also resemble that of A. aegypti, with haem-iron contributing to the 
majority of the iron needs (Zhou et al., 2007). Studies of schistosomes are suggestive that not all 
haem released is egested as waste, but is retained as a potential source of haem or iron for the parasite 
(Oliveira et al., 2000a; Sun et al., 2013). Work by Sun and colleagues suggested that Hz granules are 
degraded in the gastrodermis, specifically near microvilli adjacent to the vitelline glands, although 
further confirmation of this is required (Sun et al., 2013). These authors further argued that Fe 
released from the catabolism of Hz is utilized by vitelline cells and surrounding tissues to support 
vitellogenesis and egg production (Sun et al., 2013). Gobert et al. (2010) have shown significant up-
regulation of transferrin mRNA occurs in schistosomes cultured in vitro in the presence of RBC, 
compared to controls that are not fed with RBC. This, coupled with a positive correlation of Fer-1 
expression in S. japonicum with iron accumulation in vitelline cells and abundance of Hz granules in 
the gastrodermis (Sun et al., 2013), supports the notion that haem serves as an important Fe source. 
In human, the degradation of haem to release iron is facilitated by the presence of haem oxygenase 
(Ponka, 1999). However, a search in the genome databases of S. mansoni and S. japonicum did not 
reveal any potential HO homologues. Given the importance of iron, it is highly possible that 
schistosomes possess a haem catabolic pathway to facilitate the liberation of haem-iron. Liu et al. 
(2001) presented data to suggest that a haem oxygenase is present in S. japonicum.  However, 
contamination of the incubation media used by Liu and colleagues with enzymes from host 
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erythrocytes cannot be excluded and thus, their results should be treated with caution. Other than the 
study by Liu et al. (2001), there is no other evidence to date that support or contradict the presence 
of a haem oxygenase or haem oxygenase-like activity in these parasites (Glanfield et al., 2007). This 
highlights the lack of knowledge about haem metabolism in schistosomes.  
1.6  Haem 
Haem is a prosthetic group that consists of an Fe atom contained in the core of the heterocyclic 
tetrapyrrole, protoporphyrin IX (Ponka, 1999). Haem is a highly reactive compound, capable of 
binding and reacting with many important biological molecules (Vincent, 1989), like protein, lipid 
and DNA, and generating free radicals in the process (Klouche et al., 2004).  It is this reactive nature 
of haem that makes it an essential component of numerous important hemoproteins with diverse 
biological functions (Hou et al., 2006; Ye and Zhang, 2004). At the same time, this also renders haem 
a potentially toxic molecule (Vincent, 1989).  
1.6.1  Haem biosynthesis 
The haem biosynthetic pathway involves eight enzymes (Ponka, 1999) (refer to Figure 1.2). In non-
photosynthetic eukaryotes, the first step begins with the condensation of succinyl-CoA and glycine, 
catalyzed by the mitochondrial enzyme, aminolevulinic acid synthase (ALAS), to form δ-
aminolevulinic acid (ALA). The subsequent four steps occur in the cytoplasm. Through the action of 
aminolevulinic acid dehydratase (ALAD), two molecules of ALA combine to form porphobilinogen 
(PBG). Next, porphobilinogen deaminase (PBGD) combines four molecules of PBG to produce 
hydroxymethylbilane (HMB), while uroporphyrinogen III synthase (UROS) catalyses the ring 
closure of HMB, forming uroporphyrinogen III. Following this, uroporphyrinogen III decarboxylase 
(UROD) mediates the decarboxylation of uroporphyrinogen III to coproporphyrinogen III. 
Coproporphyrinogen III is then transported to the mitochondria, where mitochondrial 
coproporphyrinogen III oxidase (CPO) and protoporphyrinogen IX oxidase (PPO) act to catalyse the 
formation of protoporphyrinogen IX and subsequently, protoporphyrin IX (PPIX). In the final step of 
the pathway, ferrochelatase (FC) incorporates ferrous iron, Fe2+ into PPIX to form haem. 
1.6.2  Sources of parasite haem 
The haem biosynthetic pathway has been shown to be conserved through all non-photosynthetic 
eukaryotes (Heinemann et al., 2008), and even in haemoparasites (Braz et al., 2001; Kumar and Raj, 
1998; Surolia and Padmanaban, 1992). However, haematophagy presents a unique haem environment 
for these blood-feeding parasites as digestion and breakdown of host erythrocytes generates large 
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quantities of haem. Although it is essential that these parasites possess an efficient haem 
detoxification mechanism, it is also possible that they have adapted a similarly functional haem 
uptake system.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1.2. Classical haem biosynthetic pathway (Ponka, 2009). The first step of the pathway 
is catalysed by the mitochondrial enzyme, aminolevulinic acid synthase (ALAS). This generation 
of δ-aminolevulinic acid (ALA) through the condensation of succinyl-CoA and glycine by ALAS 
is the only non-conserved step in the haem biosynthetic among all known haem-producing 
organisms. In the last step of the pathway, ferrochelatase (FC), a mitochondrial enzyme, 
incorporates ferrous iron (Fe2+) into protoporphyrin IX (PPIX) to form haem. 
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1.6.3  Haem biosynthesis in blood parasites 
It is believed that the loss of an endogenous haem biosynthetic pathway is the concomitant outcome 
of the adoption of haematophagy in these parasites (Cain, 1969; Chang et al., 1975; Ohagan, 1974). 
This stems from the following factors. First, haematophagy provides an abundant source of haem. 
Secondly, most of these parasites are believed to undergo down-regulation of aerobic metabolism to 
minimize oxidative stress due to haemoglobin catabolism (Oliveira and Oliveira, 2002). Thus, haem 
biosynthesis, being an oxygen-dependent pathway (Ponka, 1999), may place undue oxidative stress 
on these parasites. However, various haemoparasites have shown varying degree of conformation to 
this hypothesis as illustrated below.   
Loss of de novo haem biosynthetic capability has been postulated for the nematodes, Ancylostoma 
caninum, Haemonchus contortus, the digeneans Philophthalmus megalurus, the tick Rhipicephalus 
microplus and the hemoflagellate Leishmania tarentola (Braz et al., 1999; Chang et al., 1975; Rao et 
al., 2005). Only the last three haem biosynthetic enzymes are believed to be functional in the 
trypanosomatids L. amazonenesis, L. infantum and Trypanosoma cruzi and the filariid nematode 
Brugia malayi (Dutta et al., 2008; Wu et al., 2009). In the malaria parasite, as well as the nematode 
Setaria digitata and the insect Rhodnius prolixus, a fully functional haem biosynthetic pathway has 
been demonstrated in vivo (Braz et al., 2001; Kumar and Raj, 1998; Surolia and Padmanaban, 1992). 
Interestingly, Plasmodium falciparum and P. berghei possess a trafficking system that salvages haem 
biosynthetic enzymes from host erythrocytes to support their haem biosynthesis and this account for 
nearly 80% of the enzymatic activities (Bonday et al., 2000). Furthermore, inhibition of this system 
has been shown to be fatal to the asexual intra-erythrocytic stage of malaria (Bonday et al., 2000).  
1.6.4  Scavenging of host haem 
The need to salvage host haem is especially important in haemoparasites with a defective haem 
biosynthetic pathway. In T. cruzi and Leishmania species, the necessity of haem salvage is supported 
by the absolute nutritional requirement for haem for growth and development (Braz et al., 2001; Dutta 
et al., 2008). Despite showing the presence of a functional haem biosynthetic pathway in malaria, the 
filarial parasite, S. digitata and R. prolixus, it is apparent that these parasites also take-up and salvage 
host haem (Braz et al., 2001; Kumar and Raj, 1998). 
1.7  Importance of haem in schistosomes 
Schistosomes encode and express numerous haemoproteins, such as cytochrome b and cytochrome 
oxidase (Coles, 1973; Glanfield et al., 2010; Liu et al., 2006; Saeed et al., 2002).  The presence of 
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these proteins highlights the importance of haem in schistosomes (Coles, 1973; Glanfield et al., 2010; 
Liu et al., 2006; Saeed et al., 2002). Besides acting as an important co-factor, haem is also an easily 
available source of iron, an element that is abundant in adult schistosomes (Jones et al., 2007). In 
schistosomes, iron is required for parasite development and reproduction (Glanfield et al., 2007) and 
is postulated to be essential for quinone-tanning of the schistosome eggshell (Jones et al., 2007). In 
humans, haem is postulated to be involved in the regulation of essential biological reaction including 
enzyme activation (Hou et al., 2006) and cellular signal transduction (Ye and Zhang, 2004). Similar 
roles for haem could also be the case in schistosomes.  
1.7.1  Haem biosynthesis and uptake in schistosomes  
According to Rao and colleagues, schistosomes are incapable of de novo haem biosynthesis (Rao et 
al., 2005).  Although Rao et al. argued for the absence of a haem biosynthetic pathway on the basis 
of enzymatic studies of S. mansoni extracts (Rao et al., 2005), it has subsequently been shown in 
genomic sequencing that all eight genes encoding the haem biosynthetic enzymes have been 
identified in both the S. mansoni (Berriman et al., 2009) and S. japonicum ( Glanfield et al., 2007; 
Liu et al., 2001) genomes or expressed sequence tag (EST) databases, with the predicted schistosome 
proteins sharing ~50% amino acid identity with human homologues. Currently, there is limited 
information about haem biosynthesis in schistosomes to determine the de novo haem biosynthetic 
capabilities of schistosomes. 
Organisms expend significant amounts of energy and resources in the process of haem biosynthesis 
(Ponka, 1999). Given that haematophagy provides these parasites with access to readily available 
haem and, potentially, iron (Glanfield et al., 2007; Sun et al., 2013; Zhou et al., 2007), an adaptation 
to salvage host haem for their own needs is likely to occur in schistosomes. Foster and Bogitsh (1986) 
have also demonstrated the uptake and incorporation of exogenous haem by S. mansoni schistosomula 
through the use of haem radiolabeled with [14C] aminolevulinic acid (ALA).  
1.7.2  Haem uptake mechanism 
All studies to date are in agreement that the dietary haem in mammals is taken up as an intact 
porphyrin via a distinct transport pathway (Grasbeck et al., 1982; Walsh et al., 1955). Although Light 
& Olson demonstrated that free haem can diffuse across membranes, they pointed out that passive 
diffusion is too slow a pathway to efficiently support the many essential biological reactions and the 
many haemoproteins that require haem (Light and Olson, 1990). Furthermore, haem binding and 
uptake has been shown to be a saturable, temperature-dependent, tissue-specific and reversible 
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process (Worthington et al., 2001) that is regulated by physiological factors such as hypoxia 
(Shayeghi et al., 2005).  
In mammals, four proteins capable of transmembrane haem or porphyrin transport have been 
identified, namely, haem carrier protein 1 (HCP1) (Shayeghi et al., 2005), ATP-binding cassette 
subgroup B member 6 (ABCB6) (Krishnamurthy et al., 2007), feline leukemia virus subgroup C 
cellular receptor 1 (FLVCR) and the ATP-binding cassette subgroup G member 2 (ABCG2) 
(Krishnamurthy et al., 2006). This supports the postulate that the transmembrane transport of haem 
is an active process. However, these proteins have been either identified as efflux transporter of haem 
(e.g. FLVCR) (Krishnamurthy et al., 2006) or are primarily involved in transport of porphyrins (e.g. 
ABCB6 and ABCG2) (Krishnamurthy et al., 2007) or folate (HCP1) (Shayeghi et al., 2005). This 
suggests that these proteins are unlikely to play an important role in the physiological uptake of haem. 
Furthermore, it remains controversial whether the uptake of dietary haem occurs through receptor-
mediated endocytosis (Grasbeck et al., 1982), or mediated by the presence of haem transporter 
(Worthington et al., 2001), or even a combination of both mechanisms.  
Many studies in haematophagous parasites have confirmed the importance of utilising and recycling 
exogenous haem for growth and development and more specifically, embryogenesis. In Leishmania 
mexicana amazonenesis (Galbraith and McElrath, 1988) and T. cruzi  (Lara et al., 2007), haem uptake 
is saturable and specific. This indicates an active transmembrane movement that is mediated by a 
transporter or receptor protein. A study by Huynh and colleagues identified a potential haem 
transporter protein (HTP), Leishmania haem responsive 1 (LHR1), in L. amazonensis, based on loose 
sequence homology with the Caenorhabditis elegans haem responsive gene 4 (CeHRG4), a 
demonstrated transmembrane haem transporter (Huynh et al., 2012). Deletion of one LHR1 allele in 
L. amazonensis results in a reduced uptake of a haem analogue and the total haem content (Huynh et 
al., 2012). Furthermore, LHR1 was found to promote haem uptake in yeast strain defective in haem 
biosynthesis in culture containing low concentration of haemin (Huynh et al., 2012). These results 
indicate that haem uptake in L. amazonesis, and by inference, most Leishmania species, is mediated 
by LHR1, a haem transporter protein (Huynh et al., 2012).  
For T. cruzi, it has been suggested that an ATP-binding cassette (ABC) transporter may mediate 
transmembrane transport of haem (Lara et al., 2007). That transmembrane transport of haem is 
mediated by an ATP-binding cassette (ABC) transporter is supported by an inhibition assay of haem 
uptake, in which accumulation of the fluorescent haem analogue palladium mesoporphyrin IX (Pd-
mP) was detected at the surface of cells after pre-incubation of parasites with cyclosporin A, an 
inhibitor of ABC transporters including P-glycoproteins (PgP) (Lara et al., 2007). Since studies in 
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Leishmania have demonstrated the lack of a functional haem biosynthetic enzymatic pathway (Chang 
et al., 1975; Pal and Joshi-Purandare, 2001), transport of exogenous haem by specific  haem 
transporter proteins could also be a source of haem for these parasites. Information on the exact 
mechanisms involved in the transmembrane movement of haem is limited, although it has been 
suggested to involve specific binding of haem or haem-bound complexes to the membrane surface, 
followed by active transmembrane transport, possibly through a proton pump (Shayeghi et al., 2005). 
In schistosomes, there is no information on whether a haem uptake system exists and if it is meditated 
by a transporter protein.  
1.8  Haem detoxification mechanism 
The ability to efficiently excrete and detoxify haem, a by-product of host erythrocyte breakdown, is 
an essential requirement for the survival of blood-feeding parasites. The importance of haem 
detoxification is supported by the numerous detoxification mechanisms identified in many parasitic 
organisms.  Such detoxification mechanisms include containment of haem within a cellular 
compartment that serves as a physical barrier (Lara et al., 2003; Tellam et al., 1999), or conversion 
of haem into the inert crystalline polymer of haem, haemozoin (Hz) (Oliveira et al., 2000a). Utilizing 
a haem detoxification pathway that is similar to that described for the malaria parasite, schistosomes 
rapidly polymerize free haem into Hz crystals, which are then voided by the parasite (Oliveira et al., 
2000a). This mechanism has also been observed for other sanguinivorous organisms, like the protistan 
Haemoproteus spp. (Chen et al., 2001), the digenean Echinostoma trivolvis (Pisciotta et al., 2005) 
and triatomine insects (Oliveira et al., 2000b). Despite sharing an identical basic unit structure with 
that of β-haematin, the Hz of each of these species possesses a distinct three-dimensional shape and 
size (Noland et al., 2003; Oliveira et al., 2000b). This suggests that there are unique factors or 
conditions in different organisms that define the Hz crystals, although similar mechanism regulates 
their formation.  
The exact mechanism mediating the formation of Hz in malaria is still unclear, with protein, lipid and 
membrane implicated. In schistosomes, lipid droplets (LDs) are believed to be involved in catalysing 
the formation of Hz (Egan et al., 2006; Soares et al., 2007). This has been supported by the following 
experimental observations: (1) both LDs and Hz are detected in the gut lumen; (2) Hz crystals 
associate with LDs in the gut lumen of S. mansoni; and (3) Hz formation is induced using lipid 
extracted from whole worm regurgitate (Oliveira et al., 2000a; Soares et al., 2007). Schistosome LDs 
have been shown to contain a neutral lipid component consisting of cholesterol, diacylglycerol and 
triacylglycerol, and a phospholipid component consisting of phosphatidylcholine, 
phosphatidylethanolamine and phosphatidylserine (Egan et al., 2006). It is postulated that lipid 
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droplets promote Hz formation by providing a hydrophilic-hydrophobic interface that acts to 
dehydrate and weaken competing water hydrogen bonding, thus promoting crystallisation (Egan et 
al., 2006; Oliveira et al., 2005). However, other factors, including proteins, may be involved in the 
formation of Hz should not be excluded.  
1.9  Haem and drugs with anti-schistosome activity 
Haem has been singled out as a potential candidate in the activation and catalysis of antimalarial 
drugs, like quinoline (Foley and Tilley, 1998) and artemisinin (O'Neill et al., 2010). First of all, haem 
is a pro-oxidant compound capable of generating free radicals and reacting with biologically 
important molecules (Vincent, 1989). In addition, free haem is present in large quantities in these 
parasites (O'Neill et al., 2010). It is suggested that these drugs could target detoxification of haem in 
malaria. However, there is no substantive evidence that supports this suggestion. Interestingly, these 
drugs have demonstrated significant anti-schistosome activity in both in vivo and in vitro studies.  
1.9.1  Quinoline  
Due to widespread resistance of the malaria parasite, P. falciparum, to quinoline-containing 
antimalarial drugs (e.g. chloroquine, quinine and mefloquine), chloroquine is only used as first line 
treatment for P. vivax malaria in areas where it still remains effective (WHO, 2010). Studies on the 
efficacy of various quinoline-containing drugs in treating schistosomiasis have shown a contradicting 
and varying reduction in worm burden, with chloroquine and mefloquine showing the most promising 
results (Keiser et al., 2009; Oliveira et al., 2003; Zhang et al., 2009). In these studies, male worms 
and the juvenile lung stage have been shown to be more resistant to the effect of the drugs than to 
female worms and adult stages (Keiser et al., 2009; Oliveira et al., 2003; Zhang et al., 2009).   
The molecular basis of the action of these drugs is not completely understood and multiple molecules 
in malarial parasites are implicated as possible targets, including haem, parasite DNA and the food 
vacuole (Foley and Tilley, 1998). The involvement of haem is supported by the following evidence: 
(1) chloroquine is only active against blood stages of Plasmodium parasites during which the parasite 
is actively degrading hemoglobin and, as result, releases high concentrations of haem as a by-product; 
(2) a reduction in pigment formation was observed in P. falciparum gametocytes obtained from 
patients treated with mepacrine and chloroquine-resistant P. berghei strains (Wood and Eaton, 1993); 
(3) chloroquine was shown to form a tight complex with free haem (Foley and Tilley, 1998). It is 
postulated that chloroquine exerts its antiparasitic effect by inhibiting the formation and elongation 
of haemozoin crystals through competitive binding to haem (Foley and Tilley, 1998). Inhibition of 
Hz formation leads to build-up of toxic haem and haem-chloroquine complexes within the parasites, 
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which in turn leads to free radical formation and damage to essential molecules like DNA, proteins 
and cell membranes (Foley and Tilley, 1998). Similarly, in schistosomes, treatment with chloroquine 
or mefloquine results in significant reduction of Hz pigment and severe damage to the gut (Zhang et 
al., 2009), indicating that the possible antiparasitic effect of quinoline may be associated with the 
inhibition of the crystallization of Hz.  
1.9.2  Artemisinin 
Artemisinin is a highly effective and well-tolerated drug that functions as a core component in the 
treatment of most forms of malaria (WHO, 2010). Various artemisinin derivatives have been used in 
the treatment of severe malaria, including artemether, artemisinin, artemotil and artesunate (WHO, 
2010). Artemisinin is a sesquiterpene trioxane lactone in which the endoperoxide bridge is essential 
for antimalarial activity (O'Neill et al., 2010). It has been suggested that iron (III) triggers 
bioactivation of 1,2,4 trioxanes to generate free radicals and reactive oxygen species (Meunier and 
Robert, 2010; O'Neill et al., 2010). This production of free radicals results in parasite death based on 
studies in malaria (Meunier and Robert, 2010; O'Neill et al., 2010). Haem is thought to be responsible 
for this bioactivation as haem-iron is abundant within the parasite (O'Neill et al., 2010). Furthermore, 
haem reacts with artemisinin much more efficiently than other iron-containing molecules, supporting 
the role of redox active haem as the primary activator of artemisinin (Meunier and Robert, 2010; 
O'Neill et al., 2010).  
Numerous parasite molecules are proposed as possible targets for arteminsinin.  These molecules 
include haem, P. falciparum ATP6 (PfATP6), the parasite membrane and mitochondria (O'Neill et 
al., 2010). It has been proposed that alkylation of haem by artemisinin to form haem-artemisinin 
adducts (Pradines et al., 2011) results in the accumulation of haem and interference in the formation 
of Hz within the parasite food vacuole (O'Neill et al., 2010). The loss of capability in detoxifying the 
harmful effect of haem through Hz crystallization leads to overwhelming oxidative stress and 
eventual parasite death (O'Neill et al., 2010). Demonstrated alkylation of the α, ß and δ carbon atoms 
of haem and detection of drug-artemisinin adducts in the spleen and urine of infected mice treated 
with artemisinin derivative supports this postulation (Robert et al., 2005). However, it does not 
provide conclusive evidence that this alkylation process plays the key role in the action of artemisinin. 
Artemisinin derivatives has shown promising results as anti-schistosome therapies in all three major 
species, resulting in significant worm burden and egg count reduction (Li et al., 2011; Mitsui et al., 
2009). Unlike PZQ, artemesinin and its derivatives are effective against both the adult and juvenile 
worms (Inyang-Etoh et al., 2004; Lescano et al., 2004; Mitsui et al., 2009). Exposure of schistosomes 
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to the compounds causes extensive ultrastructural damage of the tegument and subtegument tissues 
associated with loss in worm motor activity (Xiao et al., 2002a, b). Although effective against all 
three species, it is observed that artemisinin derivatives has a species-associated drug effect, with S. 
haematobium most vulnerable to the toxicity of the drug (Xiao et al., 2001).  
Drug studies on schistosomes using artemisinin derivatives and quinoline, which are both postulated 
to act by inhibiting the formation of Hz, show similar histological changes to the parasite, but with 
varying degrees of damage in specific structures and organs, especially the tegument and 
gastrodermis (Keiser et al., 2009; Xiao et al., 2001; Xiao et al., 2002b; Zhang et al., 2009). In 
quinoline, the greatest damage was noted in the gastrodermis, with a clear indication of cytoskeleton 
disorganization and destruction and desquamation of the gut epithelial cells (Zhang et al., 2009). In 
schistosomes treated with artemisinin derivatives, the tegument, particularly the sensory structures, 
showed extensive lysis of internal structures and degeneration or even necrosis of the nuclei of this 
syncytial lining (Xiao et al., 2002a, b). In contrast with quinoline, artemether was described to be 
more effective against the juvenile worms than the adult worms (Xiao et al., 2002a). Both artemether 
and quinoline were observed to result in focal swelling and vacuolization of the tegument and 
underlying muscles, as well as structural alteration and de-pigmentation of the gastrodermis (Xiao et 
al., 2002a, b; Zhang et al., 2009). This similar ultrastructural damage seen in the parasite treated with 
either quinoline or artemisinin derivatives is likely to be due to free radicals generated downstream 
following the activation of the two drugs. Therefore, while it is possible that quinoline works by 
inhibiting the formation of Hz, this may not be the case in artemisinin and artemisinin derivatives.  
Disruption of haem biosynthesis has been suggested as a possible mode of action of artemisinin based 
on drug studies in animals. In these studies, involving rabbits, rodents and primates, artemisinin is as 
a possible teratogenic agent capable of causing embryo death, cardiac malformations and skeletal 
defects (Clark et al., 2010; Clark et al., 2004; White et al., 2006; White and Clark, 2008). It was noted 
that the effects are greatest when the drug is administrated orally to pregnant rats throughout 
organogenesis or even as a single oral dose on day 11 of gestation (the osteogenic period) in mice 
(Clark et al., 2010; White and Clark, 2008). Embryonic erythroblasts and maternal reticulocytes, cells 
with high rates of haem biosynthesis, are believed to be the primary drug target of artemisinin (Clark 
et al., 2011). This is deduced from the following observations: (1) the survival of embryos correlates 
with maternal reticulocyte count (White et al., 2006); (2) radioactive-labelled artemisinin is 
concentrated in foetal blood and liver and maternal blood marrow (Clark et al., 2010); (3) 
administration of artemisinin results in marked reduction in the number embryonic erythroblasts and 
maternal reticulocytes (Clark et al., 2008). Furthermore, artemisinin treatment causes accumulation 
of ferric iron or haemosiderin granules in embryonic erythroblasts, indicating disruption of iron 
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homeostasis and possibly, haem biosynthesis (Clark, 2009). The teratogenic effect induced by 
artemisinin is similar to that produced by a haem synthesis inhibitor, N-phenylimide herbicide S-
53482 (Kawamura et al., 1996; White et al., 2006).  
1.10 Concluding remarks 
Schistosomiasis is a significant problem in developing countries, infecting over 200 million people 
worldwide. Problems of possible drug resistance and rapid re-infection highlight the need to develop 
new drugs and vaccines in the control of this disease. Rational design of therapeutics depends on 
developing an understanding of the basic biology of the parasites. An area that has been largely 
neglected is the metabolism of haem in schistosomes. However, there is a lack of understanding of 
haem biochemistry in schistosomes. In various anti-malarial drugs, e.g quinolines and artemisinin, 
haem biosynthesis and detoxification have been implicated in the action of these drugs. Furthermore, 
these drugs also have demonstrated significant anti-schistosome activity. Thus, the outcome of this 
project may provide insights into the mechanism of these drugs. In addition, it may also identify new 
therapeutics against schistosomiasis through characterization of an important series of metabolic 
pathways in schistosomes.  
1.11  Research aims and hypothesis 
It is reasoned that the catabolism of RBCs releases large quantities of haem that could potentially 
serves as important source of haem and iron in schistosomes. The hypothesis of this project is that 
schistosomes have a fully functional haem biosynthetic pathway. However, with ready access to 
abundant haem during the parasitic stages, it is possible that they may salvage and recycle host haem. 
Thus, it is postulated that schistosomes also possess a haem uptake mechanism to salvage exogenous 
haem from host haemoglobin.   The aims of this project are: 
1. To determine the haem biosynthetic capabilities of S. mansoni. 
2. To investigate the presence of a haem uptake system and how schistosomes utilize this 
exogenous haem. 
3. To understand the underlying mechanism mediating haem transport in S. mansoni. 
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Chapter 2 – Haem Biosynthesis in Schistosoma mansoni 
2.1 Introduction 
Haem is an iron-containing tetrapyrrole that is synthesized in an eight- or nine-step reaction 
(Heinemann et al., 2008). As a prosthetic group of a range of proteins, among them the cytochromes 
and peroxidases, haem plays a crucial role in many important biological reactions, including electron 
transfer and oxygen metabolism (Ponka, 1999). Furthermore, haem is involved in the modulation of 
gene transcription and proteins expression by directly interacting with nucleic acid and nuclear 
transcription factors (Ponka, 1999; Tsiftsoglou et al., 2006; Vincent, 1989). This, in turn, helps in the 
regulation of cell development, differentiation, signal transduction and apoptosis (Ponka, 1999; 
Tsiftsoglou et al., 2006). Although haem has many biologically important functions, it is potentially 
toxic to cells (Vincent, 1989).  
Adult schistosomes inhabit the blood vessels of their hosts, where they feed on red blood cells and 
other blood components to acquire the essential nutrients for their development and reproduction 
(Whitfield, 1979). Catabolism of host erythrocytes in haematophagy by all known parasites generates 
excessive quantities of haem that the parasite must process. The parasites use various mechanisms to 
detoxify the toxicity of haem (Toh et al., 2010). However, salvage and acquisition of exogeneous 
haem have also been universally demonstrated for many organisms (Lara et al., 2005; Surolia and 
Padmanaban, 1992). It is thought that a gradual loss of a haem biosynthesis pathway is an 
evolutionary adaption to blood-feeding, because the action of enzymes on haemoglobin liberates an 
abundance of haem and porphyrins (Chang et al., 1975). Thus diverse parasites, including the blood-
feeding nematodes Ancylostoma caninum and Haemonchus contortus (Rao et al., 2005), the tick 
Rhipicephalus microplus (Braz et al., 1999) and the excavate flagellates Trypanosoma cruzi and 
Leishmania species (Chang et al., 1975) all lack haem biosynthetic pathways.  
Demonstrated presence of numerous haemoproteins in schistosomes, including cytochromes b and 
cytochrome oxidase (Coles, 1973; Glanfield et al., 2010; Liu et al., 2006; Saeed et al., 2002) 
highlights the importance of haem in these blood-feeding trematodes. However, it is not known if 
schistosomes are dependent on host haem to support their haem-related biological reactions. Rao and 
colleagues (2005) suggested that schistosomes are incapable of de novo haem biosynthesis. However, 
as stated (Chapter 1), surveys of the genomes of S. mansoni and S. japonicum revealed the presence 
of putative genes that are homologous to the human haem biosynthetic genes (Berriman et al., 2009; 
Glanfield et al., 2007; Liu et al., 2006). Currently, there is limited information about haem 
biosynthesis in schistosomes. As such, I was interested in understanding the haem biosynthetic 
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capabilities of schistosomes by examining the functionality of two putative haem biosynthetic genes, 
δ-aminolevulinic acid dehydratase (ALAD) and ferrochelatase (FC), annotated in the S. mansoni EST 
databases (Berriman et al., 2009; Glanfield et al., 2007; Logan-Klumpler et al., 2011). These two 
genes were analysed using bioinformatics tools and their functionality were investigated using 
complementation and functional assay.   
2.2 Materials and methods 
2.2.1 Maintenance of Parasites  
All work involving the use of mice was approved under Project P1289 by the Animal Ethics 
Committee of the Queensland Berghofer Medical Research Institute (QIMRB) and was performed by 
staff trained in animal handling, as required by the ethics protocol. Adult S. mansoni (Puerto Rican 
strain) worms were perfused from ARC Swiss mice 6-8 weeks after percutaneous challenge with 
cercariae shed from Biomphalaria glabrata snails. Eggs were isolated by digesting infected livers in 
collagenase B and purification by differential centrifugation in Percoll (GE Healthcare, Sweden) 
(Dalton et al., 1997). Eggs were hatched in conditioned water under bright light and the hatched 
larvae, miracidia, were collected from the supernatant by pipette (Dalton et al., 1997). In order to 
obtain mechanically transformed sporocyst, miracidia were transferred into modified MEMSE-J 
(minimum essential medium for S. japonicum eggs) (Table 1) and incubated for two days at 23oC 
under low oxygen conditions (Kawanaka et al., 1985). These culture conditions are to mimic the 
physiological and biochemical conditions that mediate the transformation of Schistosoma miracidium 
into the sporocyst after penetration into appropriate snail species. Cercariae were obtained by 
exposing snails with patent infection to a bright light for an hour. Schistosomula were obtained by 
mechanical transformation of cercariae. For this, the cercariae were forced through a 22-gauge 
emulsifying needle twenty-five times to separate the cercarial tails from the bodies (James and Taylor, 
1976) and the tails were removed further by centrifugation at 500 xg for 10 min through a 60% Percoll 
gradient (Lazdins et al., 1982), followed by three washes in RPMI medium (10 mM Hepes, 200 U/ml 
Penicillin-Streptomycin (Pen/Strep)). The mechanically-transformed schistosomula were then 
incubated for 5 days at 37oC in modified Basch’s medium (Table 2) under 5% CO2 atmosphere 
(Basch, 1981). 
 
 
20 
 
 
2.2.2 Isolation of total S. mansoni RNA and synthesis of complementary DNA 
Total RNA was isolated from different life-cycle stages of S. mansoni by phase extraction using 
TRIZOL reagent (Life Technologies, Germany) and column chromatography using a RNase Mini Kit 
(Qiagen, Germany) as described (Hoffmann et al., 2002) and stored at -80oC. Briefly, the parasites 
were homogenized in TRIZOL using RNase-free pestle and 0.2 mL of ice-cold chloroform was added 
for every 1 mL TRIZOL added. The homogenized mixture was then incubated at room temperature 
for 2 min and centrifuged (12,000 xg, 14 min) at 4oC to separate the nucleic acid and protein phases. 
Next, the colourless phase, which contains nucleic acid, was aliquoted and an equal volume of 70% 
ethanol was added and mixed gently. RNA was extracted from the mixture using RNase Mini Kit 
(Qiagen, Germany), following manufacturer’s instruction. The integrity and purity of isolated total 
RNA was analysed using Bioanalyzer RNA Pico LabChip (Agilent, USA) and the quantity was 
determined using a ND-1000 spectrophotometer (Thermo Scientific, USA). Complementary DNA 
Table 2.1. Modified MEMSE-J (Minimum 
Essential Medium for Schistosoma japonicum
eggs) (Kawanaka et al., 1983) 
Constituents Concentration /L 
NaCl 6.8 g 
KCl 0.4 g 
CaCl2 0.2 g 
MgCl2.6H2O 0.2 g 
NaH2PO4.2H2O 0.15 g 
NaHCO3 2 g 
Glucose 2 g 
Foetal Calf 
Serum 10% (V/V) 
Pen-Strep 2000 U 
 
The components were dissolved in 800ml 
DMEM (Life Technologies, Germany), the pH 
was adjusted to 7.2 with 1 N NaOH and the 
volume adjusted to 1 litre. The medium was then
sterilized by filtration through a 0.22 μm filter 
and stored at 4oC.  
Table 2.3 Modified Basch’s Medium (Basch, 
1981)  
 
Constituents Concentratio
n/L 
Lactalbumin 
hydrolysate   1 g 
Glucose  1 g 
Hypoxanthine  0.5 mM 
Serotonin  1 mM 
Insulin (crystalline)  8 g 
Hydrocortisone  1 mM 
Triiodothyronine  0.2 mM 
MEM vitamins  0.5X 
Schneider’s medium 5% 
Foetal Calf Serum 10% 
Hepes 10m M 
Pen/Strep 2000 U 
Glutamax 1% (V/V) 
 
 
The components were dissolved in Basal 
Medium Eagle (BME) (Life Technologies, 
Germany) to make up the total volume. 
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(cDNA) was synthesized from 100 ng of total RNA using QuantiTect Whole Transcriptome kit 
(Qiagen, Germany) in accordance with manufacturer’s instruction. 
2.2.3 Sequence analysis and phylogeny 
Two annotated protein sequences, Smp_045810 and Smp_140790, were identified in the genome 
database from SchistoDB (http://www.genedb.org/Homepage/Smansoni) and defined as putative S. 
mansoni aminolevulinic dehydratase (Sm-alad) and ferrochelatase (Sm-fc) respectively (Logan-
Klumpler et al., 2011).  Protein sequences of SmALAD and SmFC were aligned with haem 
biosynthetic genes of S. japonicum, the mouse and humans using Clustal Omega (Sievers et al., 
2011).  The inferred protein structures were predicted using Phyre, a protein homology/analogy 
recognition engine (Kelley and Sternberg, 2009).  
 
Multiple sequence alignment and a phylogenetic tree was constructed using MEGA 5.0 software. 
Known and putative ALAD and FC sequences from different species of vertebrates and invertebrates 
were selected for construction of the molecular phylogenetic trees of both proteins. The sequences 
were aligned using ClustalW (Larkin et al., 2007) and trees were constructed using MEGA 5 (Tamura 
et al., 2011). Minimum evolution phylogenetic trees for both ALAD and FC were constructed using 
Jones-Taylor-Thornton (JTT) substitution model (Jones et al., 1992), with the assumption of uniform 
evolution rates among sites. The data were bootstrapped 1000 times with resulting values displayed 
on the branches of the phylogenetic tree.  
2.2.4 Real-time PCR 
Real Time PCR (qPCR) of Sm-alad and Sm-fc was performed on all life cycle stages of S. mansoni. 
Forward and reverse primers (Sigma-Aldrich, USA) were designed from unique sequences of 
schistosome ALAD and FC ESTs to amplify sequences of approximately 136bp and 158bp, 
respectively (Table 3). The reaction mixture consisted of 5 μl (50 ng/μl) synthesized cDNA, 2 μl (5 
nmol) primers (reverse and forward), 10 μl SYBR Green (Life Technologies, Germany) and 3 μl 
water. The thermal cycling profile for the reaction was as follows: hot start at 95oC for 10 min 
followed by 40 cycles of 95oC for 30 s, 55oC for 30 s and 72oC for 30 s. Three technical replicates 
were performed in this experiment. All reactions were performed using a Corbett Rotor-Gene 6000 
real time thermal cycler (Qiagen, Germany) and data were analysed by Corbett Rotor-Gene 6000 
Software (Qiagen, Germany). The data were quantified against Sm-alad and Sm-fc standard curve of 
the different life cycle stages of S. mansoni. This was normalized against the housekeeping gene, 
DNA segregation ATPase (TC15682) (Verjovski-Almeida et al., 2003) for the different stages and 
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tissue. This gene was chosen as the transcript abundance was shown to remain constant in the different 
stages and tissue (Gobert et al., 2010).  
2.2.5 Cloning and sequencing of full length Sm-alad and Sm-fc 
Human and E. coli haem biosynthetic enzymes coding sequences (CDS) cloned into pET21a+ 
expression vector  (human ALAD, human FC and E. coli FC) were generously provided by Dr. Barton 
Slatko, New England Biolabs (Wu et al., 2009). Primers to amplify the full-length sequence for the 
CDS, Ec-alad, Sm-alad and Sm-fc were designed using sequencing data available from NCBI 
(http://www.ncbi.nlm.nih.gov) and SchistoDB (http://www.genedb.org/Homepage/Smansoni) 
(Logan-Klumpler et al., 2011). BamHI restriction enzyme recognition site were added to all forward 
primers and XhoI restriction enzyme recognition were added to all reverse primers to aid subsequent 
cloning process (Table 2.3).  
 
 
List of oligonucleotides used for real-time PCR and cloning 
 
Sequence (5’ – 3’) 
Gene Forward Reverse 
Product 
Size (bp) 
Real-time PCR Primers 
Sm-alad 
TCAGTGCCGAGAATCTTGT
G 
CGAATAGGATGCAACCGA
AT 
136 
Sm-fc TGGGGTGGAAAGTATTGA
GC 
TGAGGATGAAACAGAGCG
TG 
158 
Cloning Primers 
Sm-alad 
cgggatccATGAATTCTTACTC
ATCCCCTCC 
ccgctcggagTTAAGCATAAGC
AAACATTGTCTG 
1017 
Sm-fc cgggatccATGCCATGTTTGCG
TTGCGTGG 
ccgctcggagACGTACATACTC
ACT 
1279 
Table 2.2. List of oligonucleotides used for real-time PCR and cloning. BamHI restriction 
enzyme recognition site (in lower case) were added to all forward primers for cloning and XhoI 
restriction enzyme recognition (in lower case) were added to all reverse primers for cloning.  
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The CDS were amplified with AmpliTaq® Gold DNA polymerase (Life Technologies, Germany). 
The PCR products and pET-21a (+) vector (Merck Millipore International, Germany) were digested 
by restriction enzymes BamHI and XhoI (New England BioLabs, UK) at 37oC for three hours. The 
vector was dephosphorylated using calf-intestinal alkaline phosphatase (CIP) (New England 
BioLabs, UK). The products were purified using QIAquick ® Purification kit (Qiagen, Germany) 
according the manufacturer’s instructions. Ligation of the vector and insert was performed using 
T4DNA Ligase (Promega, USA) and incubated at 16oC overnight. The ligation mixture was added to 
One Shot ® TOP10 (Life Technologies, Germany) chemically competent E. coli cells. The cells were 
transformed with heat shock (42oC for 45 sec), followed by the addition of super optimal broth with 
catabolite repression (SOC) (2% (W/V) tryptone, 0.5% (W/V) yeast extract, 10 mM NaCl, 2.5 mM 
KCl, 10 mM MgCl2 and 20 mM glucose) medium. The mixture was incubated for one hour with 
shaking (225 rpm) at 37oC and subsequently, plated onto LB (1% (W/V) tryptone, 0.5% (W/V) yeast 
extract, 1% (W/V) NaCl) agar plates containing 50 µg/mL Ampicillin (Sigma-Aldrich, USA). 
Ten single colonies per construct were screened with PCR using T7 (pET) promoter 
TAATACGACTCACTATAGG and terminator CTGTTATTGCTCAGCGGTG primers for the 
presence of insert. Colonies containing the right-sized insert was cultured overnight in LB medium 
containing antibiotics and plasmids were purified from the culture medium with QIAprep® Spin 
Miniprep kit (Qiagen, Germany) as per manufacturer’s instructions. Purified plasmids were 
sequenced at concentration of ¼ reactions using Big Dye 3.1 in the QIMRB sequencing facility as 
instructed in the sequencing protocol to verify insert sequences.  
2.2.6 Functional expression of schistosomes ALAD and FC in mutant E. coli  
E. coli hemB (ALAD) mutant strain RP523 (Li et al., 1988) was obtained from the E. coli Genetic 
Stock Center (http://cgsc.biology.yale.edu) while hemH (FC) deletion strain VS200 was a generous 
gift from Dr Harry A Dailey, University of Georgia (Nakahigashi et al., 1991).  RP523 is a mutant E. 
coli strain that possess a mutated HemB gene  (ALAD) and thus, it grows poorly in medium that is 
not supplemented with PBG or haem (Li et al., 1988). VS200 is a mutant of E. coli, in which the part 
of FC gene is deleted. Due to this defect, VS200 are unable to grow well in medium that is not 
supplemented with haem (Nakahigashi et al., 1991). Haem biosynthetic genes, SmALAD and SmFC 
from S. mansoni, were cloned into pET21a+ vector. Human and E. coli ALAD and FC genes were 
used as positive control while empty pET21a+ vector was used as negative control for the 
complementation assays. 
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Transformants were selected on 20 µg haemin-containing LB plates with 50 µg/mL of ampicillin and 
incubated at 37oC overnight. To determine functionality of the genes, the growth rate of the 
transformed mutant E. coli were determined for solid and liquid growth media. The fresh transgenic 
E. coli, grown to OD600 of 0.6 to 0.8, were diluted to OD600 of 0.1 before initiating the growth assay. 
The diluted E. coli cells were plated in LB agar and incubated overnight at 37oC.  For liquid medium, 
the E. coli cells were cultured in LB medium containing 0.1mM isopropyl b-D-thiogalactopyranoside 
(IPTG) (AppliChem, Germany) and grown in 37oC shaker (200 rpm). Cell growth was measured (at 
OD600) at hourly intervals for ten hours.  
2.2.7 Expression and purification of recombinant schistosomes ALAD and FC  
Cloned SmALAD and human ALAD were expressed in E. coli BL21 cells, while SmFC and human 
FC were expressed in E. coli JM109 cells. Bacterial cells were cultured in 2YT medium at 37oC 
(200rpm) until the OD600 reached approximately 0.6. Induction of protein expression was initiated by 
adding IPTG to a final concentration of 100mM for SmALAD and hALAD and 10mM for SmFC and 
hFC. The cultures were then incubated for 18 – 24 hours at 16oC (200rpm), before harvesting by 
centrifugation (6,000 xg, 20min).   
 
For SmALAD and hALAD, bacterial cells were suspended in 30mL of solution 1 (50mM Tris, pH8.0, 
300mM Nacl, 10µg/mL phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich, USA)) and frozen 
overnight at -80oC. After this, the cells were disrupted by passing through a French Press twice and 
centrifuging at 10,000 xg for 20 min to separate the cytoplasmic fraction from the membrane fraction. 
The proteins were purified under native conditions, using agarose-conjugated anti-T7 tag (Sapphire 
Bioscience, Australia) or HIS-Select® Nickel affinity gel (Ni-NTA) (Sigma-Aldrich, USA). A 10K 
NWML (nominal molecular weight limit) centrifugal filter device (Pall Corporation, USA) was used 
to concentrate the eluted protein.  
 
For SmFC and hFC, purification of the proteins was performed as previously described (Dailey et al., 
1994) with slight modification. The bacterial cells were suspended in 30mL of solution 1 with 20% 
glycerol and frozen overnight at -80oC. After freezing, the cells were disrupted through 2 rounds of 
French press and centrifuged at 10,000 xg for 20 min to separate the cytoplasmic fraction from the 
membrane fraction. The membrane fraction was suspended in 20mL of solubilisation buffer (20mM 
Tris, pH 8.1, 10 µg/mL PMSF, 1.0% sodium cholate (Sigma-Aldrich, USA) and 1.0M potassium 
chloride (Sigma-Aldrich, USA)) and sonicated twice (15-30 s). The sonicated mixture was then 
centrifuged (100,000 xg for 60 mins) to pellet the membrane fraction. The supernatant fraction, which 
contains the solubilised ferrochelatase, was carefully removed and brought to 45% ammonium 
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sulphate. The membrane pellet was resuspended in 10mL solution 1 containing 20% glycerol and the 
proteins were purified under native conditions, using HIS-Select® Nickel affinity gel (Ni-NTA). A 
10K NWML centrifugal filter device was used to concentrate the eluted protein. The purified proteins 
were confirmed by Western blot with rabbit polyclonal anti-T7 antibodies (Genscript Corporation, 
USA) and quantified using a Bovine Serum Albumin (BSA) (New England BioLabs, UK) gradient 
gel. All proteins were stored at -80oC.  
2.2.8 Extraction of parasite materials for functional assay 
All procedures were performed at 4oC as described in Rao et al. (2005) with modifications. Adult 
paired worms (approximately 100 pairs) were washed extensively in 1xPBS and resuspended in 
solution A (1x PBS, 1 µg/mL aprotinin (Sigma-Aldrich, USA), 1 µg/mL leupeptin (Sigma-Aldrich, 
USA), 2mM sodium orthovanadate (Sigma-Aldrich, USA) and 10 µ/mL PMSF). The worm 
suspension was homogenized for four minutes using a hand homogenizer. The homogenate was 
centrifuged (1,000 xg, 5 mins) to remove cell debris and nuclei. The supernatant was collected and 
centrifuged (12,000 xg, 30 mins) to separate the cytosolic and mitochondrial fraction. The supernatant 
was collected as a cytosol-enriched fraction, while the pellet, a fraction enriched in mitochondria, was 
resuspended in lysis buffer (solution A containing 1% Nonidet P-40 (NP40) (Sigma-Aldrich, USA), 
0.5% sodium deoxycholate, 0.1% SDS and 1 mM dithiothreitol (DTT) (Sigma-Aldrich, USA)) and 
incubated on ice for 20min. After this, the lysate was centrifuged at 15,000 xg for 5 min. The resulting 
supernatant was kept as the solubilised enriched mitochondrial fraction. All protein extract were 
stored at -80oC. Total protein concentration of each fraction was determined using Bradford protein 
asssay. 
2.2.9 Functional assays of schistosome ALAD and FC 
The purified expressed protein, SmALAD and SmFC, were used to determine the functionality of the 
enzymes with the purified expressed protein of human haem enzymes used as positive control. 
Activities for ALAD and FC were determined as described (Spencer and Jordan, 1993) (Camadro 
and Labbe, 1988) and cytosolic and mitochondrial fraction of the worm extract were used for ALAD 
and FC assay respectively.  
 
Enzyme activities of the purified recombinant ALAD proteins were performed in 50 mM potassium 
phosphate buffer (Sigma-Aldrich, pH 6.8) containing 1 µg protein, 50 µM zinc sulphate (Sigma-
Aldrich, USA), 5 mM substrate δ-aminolevulinic acid (ALA) (Frontier Scientific, USA) and 10 mM 
BME 2-mercaptoethanol (BME) (Sigma-Aldrich, USA), in a total volume of 100 µL. All assays were 
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initiated by the addition of ALA and incubated at 37oC for 30 min. Reactions were stopped by mixing 
the assay solutions with an equal volume of stop buffer (0.1 M mercury chloride (HgCl2) (Sigma-
Aldrich, USA) in 12% Trichloroacetic acetic (TCA) (Sigma-Aldrich, USA) and incubation on ice for 
3 min. The mixture was centrifuged (12,000 xg, 3min) and an aliquot of 100µL was mixed with equal 
volume of modified Ehrlich reagent (20g/L p-dimethyl aminobenzaldehyde (DMAB) (Sigma-
USA), 50% (V/V) 95% ethanol and 50% (V/V) concentrated hydrochloric acid) for 10 min. The 
product, porphobilinogen (PBG), was estimated by measuring the absorbance at 555nm using a 
Biotek Synergy H4 multi-mode plate reader (Life Technologies, Germany). This was quantified 
against a calibrated curve of standard solution of PBG (Frontier Scientific, USA) in 50 mM phosphate 
buffer, pH 6.8 containing 10 mM BME. The assay was linear from 0.025 to 0.875 mM. The reaction 
was calculated as concentration of PBG produced per mg of protein over a one hour time period (nmol 
PBG/mg of protein.hour).  
 
Enzyme activities of the purified recombinant FC proteins were performed in 100 mM Tris-HCl, 
(Sigma-Aldrich, pH 7.6) containing 1 µg protein, 1 mM palmitic acid (Sigma-Aldrich, USA), 5 µM 
zinc sulphate (ZnSO4) (Sigma-Aldrich, USA) and 1 µM protoporphyrin IX (PPIX) (Frontier 
Scientific, USA) in a total volume of 200 µL. All assays were initiated by the addition of PPIX and 
incubated at 30oC. The disappearance of the PPIX (excitation/emission: 410/632nm) and formation 
of zinc-protoporphyrin IX (Zn-PPIX) (excitation/emission: 420/587nm) were measured on 10-minute 
intervals for one hour using a Synergy H4 multi-mode plate reader. The product, Zn-PPIX, was 
estimated by measuring the consumption of PPIX during the reaction. This was quantified against a 
calibrated curve of standard solution of PPIX in 100mM Tris-HCl (pH 7.6) and the assay was linear 
from 0.0125 to 0.8 µM. The reaction was calculated as concentration of Zn-PPIX produced per mg 
of protein in one hour (mmol Zn-PPIX/mg of protein.hour). 
2.3 Results 
2.3.1 In silico analysis of schistosome haem biosynthetic genes 
Sm-alad. The putative ALAD of S. mansoni (Sm-alad, Smp_045810) is a 999-bp cDNA, consisting 
of seven exons with an ORF of 332 amino acids and a predicted molecular mass (Mr) of 36,669 Da. 
The SmALAD protein shares strong amino acid identity (91%) with a putative ALAD of S. japonicum 
and approximately 57% amino acid identity with the human ALAD protein. Based on sequence 
comparison, the structure prediction of SmALAD was modelled after the Saccharomyces cerevisiae 
ALAD protein, which consist of eight alpha-helices and parallel beta-strands alternating along the 
peptide backbone. This triosephosphate isomerase (TIM) alpha/beta-barrel structure (Figure 2.1A) is 
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characteristic of proteins belonging to the ALAD family (Erskine et al., 1997). Sequence alignment 
of SmALAD with homologous proteins of S. japonicum, mouse and human (Figure 2.2) identified 
the presence of highly conserved residues (Lys 210 and 263, Tyr 207, 216 and 287, Met 18, Val 289 
and Gln 236) that are associated with enzyme activity of ALAD (Kervinen et al., 2000). In addition, 
the presence of the cysteine-rich zinc binding motif (DXCXCX(Y/F)X3G(H/Q)CG) and the absence 
of an allosteric Mg2+ determinant was noted for SmALAD  (Jaffe, 2004; Kervinen et al., 2001) 
(Figure 2.2).  
Sm-fc. The 1254-bp putative ferrochelatase gene of S. mansoni (Sm-fc, Smp_140790) is made up of 
seven exons, and has a predicted ORF of 417 amino acids and Mr of 47,815 Da. SmFC protein shares 
85% and 52% amino acid identity with S. japonicum and human FC proteins respectively. Based on 
sequence comparison with the human ferrochelatase, the structure of SmFC (Figure 2.1B) was 
predicted to consist of two similar domains that make up a four stranded parallel beta sheet flanked 
by alpha helices (Al-Karadaghi et al., 1997). Sequence alignment of SmFC (Figure 2.3) with 
ferrochelatase proteins of S. japonicum, mouse and human identified the presence of His 263, an 
important residue in the binding of metal ions (Kohno et al., 1994). The SmFC sequence was also 
found to contain the distinctive binding motif for the iron-sulphur [2Fe-2S] cluster (Ferreira et al., 
1995; Ta and Vickery, 1992) (Figure 2.3) This motif, which consists of a 30-residue region 
(CX7CX2CX4C), was conserved among the mammalian FC (Ferreira et al., 1995).  
2.3.2 Molecular phylogeny 
Known and putative ALAD sequences from prokaryotes and eukaryotes were used to construct the 
phylogenetic tree. Six clusters are indicated in the tree, following the general phylogeny of the 
organisms (Figure 2.4A). A sister relationship between the putative ALADs of the trematodes S. 
mansoni, S. japonicum and Clonorchis sinensis is well supported by the bootstrap values. Sequences 
from the bacteria and plants form a clear outgroup. The trematode clade is shown to form a distinct 
cluster from the vertebrate proteins. Overall, groupings throughout the tree are supported by high 
bootstrap values (≥55). 
Known and putative FC sequences from vertebrates, invertebrates and bacteria were chosen to 
construct a molecular phylogeny of FC (Figure 2.4B). The tree shows clustering of the mammals. 
Sequences from the bacteria is shown to form a clear outgroup from the others protein sequences. As 
seen in the phylogenetic tree of ALAD, sequences from S. mansoni, S. japonicum and C. sinensis 
clustered together as distinct clade from the vertebrate proteins. Overall, high bootstrap values (≥74) 
are seen through the tree.  
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2.3.3 Stage specific expression of SmALAD and SmFC 
Results of qPCR showed that Sm-alad transcripts were detected in all life-cycle stages investigated, 
with the highest level observed in the adult female worms and the lowest level in the male worms 
(Figure 2.5A). Sm-fc was also shown to be transcribed in all life cycle stages. The highest levels of 
transcription of Sm-fc was noted in the mechanically transformed sporocyst stage while lowest level 
of transcription occurred in mechanically transformed schistosomula cultured in the absence of RBCs 
respectively (Figure 2.5B) 
  
Figure 2.1. Schematic representation of the structure of haem biosynthetic enzymes of S. 
mansoni. A) Predicted structure of SmALAD which consist of eight alpha-helices and parallel beta-
strands alternating along the peptide backbone (Erskine et al., 1997). B) Predicted structure of 
SmFC, two similar domains of a four stranded parallel beta-sheet flanked by alpha-helices (Al-
Karadaghi et al., 1997). Image coloured by rainbow from N to C terminus. 
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Figure 2.2: ALAD sequences alignment. Multiple sequence alignment (Clustal Omega) of ALAD amino 
acid sequences of S. mansoni (GeneDB accession no.: Smp 045810, SmFC). Sequences included S. 
japonicum (Sjp 0075570, SjpALAD), human (Genbank accession  no.: NP 000022, hALAD) and mouse 
(NP 032551, mALAD) and The highly conserved residues (in red letters) - Lys 210 and 263, Tyr 207, 216 
and 287, Met 18, Val 289 and Gln 236, that is associated with enzyme activity of ALAD [5]. Cysteine-rich 
zinc-binding motif, DXCXCX(Y/F)X3G(H/Q)CG [7] (where D is aspartic acid, C is cysteine, Y is tyrosine, 
F is phenylalanine, G is glycine, H is histidine, Q is glutamine, X is any amino acid and the number in 
subscript correspond to the number of amino acids) is shown (highlighted in yellow). Letters in blue shows 
the determinant for the absence of allosteric Mg2+ (arginine-serine (A-R) pair replacing the glutamine (E) 
residue outside of the active side) [7]. Letter highlighted in red shows shared 10-residues, Xh3XH[S/R]FSp, 
between schistosome ALAD proteins (where X is any amino acid, h is any hydrophobic amino acids, the 
number in subscript correspond to the number of amino acids, H is histidine, S is serine, R is arginine, F is 
phenylalanine and p is any polar amino acid).  
 
 
mALAD        MHHQSVLHSGYFHPLLRSWQTAASTVSASNLIYPIFVTD----------VPDDVQPIASL 50 
hALAD        MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTD----------VPDDIQPITSL 50 
SmALAD       MNSTHPLHSSYSNLLFRQWQTANYKVSAENLVYPIFLRYIILFSHSFSQDPDCDKIITSL 60 
SjpALAD      MHYTHPLHSSYSKLLFRQWHSADYKFGAENLVYPIFLRYDVLIFHRFSHDPECDVIITSL 60 
             *.    ***.* . *:* *::*  .. *.**:****:             *:    *:** 
 
mALAD        PGVARYGVNQLEEMLRPLVEAGLRCVLIFGVPSRVPKDEQGSAADSEDSPTIEAVRLLRK 110 
hALAD        PGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRK 110 
SmALAD       IDQRRIGCNRIIEFLTPLVAKQLKSVLLFGTISKDQKDATGSACDTPNSPVIQAIKLLKS 120 
SjpALAD      IDQRRIGCNRIIEFLAPLVAKQLKSVLLFGTVNKDQKDATGSACDAPNSPVIQAIKLLKS 120 
                 * * ::: *:* ***   *:.**:**. .:  **  ***.*: :**.*:*::**:. 
 
mALAD        TFPSLLVACDVCLCPYTSHGHCGLLSENGAFLAEESRQRLAEVALAYAKAGCQVVAPSDM 170 
hALAD        TFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDM 170 
SmALAD       KFPDLIVICDVCLCAYTDSGHCGILRDDGCLDVPRTLERLAEISKRFALEGADVIAPSDM 180 
SjpALAD      AFPNLVVICDVCLCAYTDSGHCGILRDDGCLDVPKTVERLAEISKRFALEGADVIAPSDM 180 
              **.*:* ****** **. ****:* ::*.: . .: :****::  :*  *.:*:***** 
 
mALAD        MDGRVEAIKAALLKHGLGNRVSVMSYSAKFASCFYGPFRDAAQSSPAFGDRRCYQLPPGA 230 
hALAD        MDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGA 230 
SmALAD       MDGRVKKIKMAIESIGLSGKVAVMSYSAKFASCLYGPFRDAAQSAPSFGDRRHYQLPPGA 240 
SjpALAD      MDGRVKKIKMAIESIGLTEKVAVMSYSAKFASCLYGPFRDAAQSAPSFGDRRHYQLPPGA 240 
             *****: ** *:   **  :*:***********:********:*:*:***** ******* 
 
mALAD        RGLALRAVARDIQEGADMLMVKPGLPYLDMVREVKDKHPELPLAVYQVSGEFAMLWHGAQ 290 
hALAD        RGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQ 290 
SmALAD       KGLALRAAIRDANEGADFIMVKPGLPYLDIVNELRQLLPHHPLAVYHVSGEYAMLKHAAN 300 
SjpALAD      KGLALRAAIRDANEGADFIMVKPGLPYLDIINELRQLLPHHPLAVYHVSGEYAMLKHAAN 300 
             :******. ** .****::*****:****::.*:::  *. *****:****:*** *.*: 
 
mALAD        AGAFDLRTAVLETMTAFRRAGADIIITYFAPQLLKWLKEE--- 330 
hALAD        AGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE--- 330 
SmALAD       AGAIDLKQAALELMTAFRRAGKFAYQTMFAYA----------- 332 
SjpALAD      AGALDLKQAALELMTSFRRAGASIIVTYLTPYLLELDLSESCK 343 
             ***:**: *.** **:*****     *  :              
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Figure 2.3. FC sequences alignment. Multiple sequence alignment (Clustal Omega) of FC amino 
acid sequences of FCs from S. mansoni (GeneDB accession no.: Smp 140790, SmFC), S. 
japonicum (Sjp 0114760, SjpFC), human (GenBank accession no. : NP CAB65962, human FC) 
and mouse (AAA37615, mouse FC).  His263, an important residue for binding of metal ions 
(Kohno et al., 1994), is displayed as red letter. The 30-residues regions, containing the 
[CX7CX2CX4C] sequences, is the distinctive binding motif for the iron-sulphur [2Fe-2S] cluster 
(Ta and Vickery, 1992) (where acid, C is cysteine, X is any amino acid and the number in subscript 
correspond to the number of amino acids), are highlighted in yellow. Residues highlighted in blue 
shows shared 16-residues, [EX2FXGVEXIX2PX3], between schistosome FC proteins (where E is 
glutamic acid, F is phenylalanine, G is glycine, V is valine, S is serine, I is isoleucine, P is proline 
and X is any amino acid, the number in subscript correspond to the number of amino acids,). 
hFC MRSLGANMAAALRAAGVLLRDPLASSSWRVCQPWRWKSGAAAAAVTTETAQHAQGAKPQV 60
mFC ----------------------KHCGSSRACQPWRCQSGAAVAA-TTEKVHHAKTTKPQA 37
SmFC --------------------------MFALRGHLRYYFG--------------NRYCVHN 20
SjFC -------------------------------------------------------- 0
hFC QPQKRKPKTGILMLNMGGPETLGDVHDFLLRLFLDQDLMTLPIQNKLAPFIAKRRTPKIQ 120
mFC QPERRKPKTGILMLNMGGPETLGEVQDFLQRLFLDRDLMTLPIQNKLAPFIAKRRTPKIQ 97
SmFC RQCSQKAKTGIMLLNMGGPETTKEVQNFLTRLFSDKEIIRMPFQDLLARFVAWRRSPKIE 80
SjFC ------------------------------------------------------------ 0
hFC EQYRRIGGGSPIKIWTSKQGEGMVKLLDELSPNTAPHKYYIGFRYVHPLTEEAIEEMERD 180
mFC EQYRRIGGGSPIKMWTSKQGEGMVKLLDELSPATAPHKYYIGFRYVHPLTEEAIEEMERD 157
SmFC KQYSHIGGGSPILYWTKVQGEMMIKHLDAISPETAPHRFYVAFRYVHPLVESCVNEIERD 140
SjFC ---------------------MITRNLDIISPETAPHKFYVAFRYVHPLVESCVNEMERD 39
: : ** :** ****::*:.*******.*..::*:***
hFC GLERAIAFTQYPQYSCSTTGSSLNAIYRYYNQV----------------GRKPTMKWSTI 224
mFC GLERAIAFTQYPQYSCSTTGSSLNAIYRYYNEV----------------GQKPTMKWSTI 201
SmFC GVERVVAFSQYPQYSCTTSGSSLNTVVRHYESEEKNFNGVESIELPSVQNNRPGPIWSFI 200
SjFC CVERVVAFSQYPQYSCTTAGSSLNAIVRHYESNEKMFNGVESIELPFLPNNSPGPIWSFI 99
:**.:**:*******:*:*****:: *:*:.                  . *   ** *
hFC DRWPTHHLLIQCFADHILKELDHFPLE-KRSEVVILFSAHSLPMSVVNRGDPYPQEVSAT 283
mFC DRWPTHPLLIQCFADHILKELNHFPEE-KRSEVVILFSAHSLPMSVVNRGDPYPQEVGAT 260
SmFC DRWPVFPPLIDSFASKIRDELQSIEDETERANTVLIFSAHSIPLSVVNRGDPYPQEVGAT 260
SjFC DRWPVYPSLVNAFASKILKELQGIRDEKERANTVLIFSAHSIPLSVVNRGDPYPQEVGAT 159
****..  *::.**.:* .**: :  * :*::.*::*****:*:*************.**
hFC VQKVMERLEYCNPYRLVWQSKVGPMPWLGPQTDESIKGLCERGRKNILLVPIAFTSDHIE 343
mFC VHKVMEKLGYPNPYRLVWQSKVGPVPWLGPQTDEAIKGLCERGRKNILLVPIAFTSDHIE 320
SmFC VHAIMKQLNFSWPYRLTWQSKVGPAAWLGPSTEDTLYGLSRLGYRHALLIPVAFTLDHIE 320
SjFC VHAIMKQLNFSWPYRLTWQSKVGPAAWLGPSTADTLYGLSRLGYRHAILIPVAFTLDHIE 219
*: :*::* :  ****.*******  ****.* ::: **.. * :. :*:*:*** ****
hFC TLYELDIEYSQVLAKECGVENIRRAESLNGNPLFSKALADLVHSHIQSNELCSKQLTLSC 403
mFC TLYELDIEYSQVLAQKCGAENIRRAESLNGNPLFSKALADLVHSHIQSNKLCSTQLSLNC 380
SmFC TLYEMDIEYCSEVAAKAGMVSVRRSQSLNGDPAFGQGLAELVLDHLRRGDPCSKQFMLRC 380
SjFC TLYEMDVEYCTEVASKAGMVTVRRSQSLNDDPAFSQGLAELVLDHLRRGEPCSKQFMLRC 279
****:*:**.  :* :.*  .:**::*** :* *.:.**:** .*::  . **.*: * *
hFC PLCVNPVCRETKSFFTSQQL----------------- 423
mFC PLCVNPVCRKTKSFFTSQQL----------------- 400
SmFC PMCTNPSCERTRKFIMAQKEQVRDWTTLHLSNSEYVR 417
SjFC PMCTNPSCERTRKFIMTQKKRLHVWTNVHLSNNLYA- 315
*:*.** *..*:.*: :*:                  
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Figure 2.4. Phylogenetic trees of haem biosynthetic enzymes, ALAD and FC. A) ALAD 
proteins. Minimum evolution phylogenetic tree from known and putative ALAD protein sequences 
from a variety of organisms. B) FC proteins. Minimum evolution phylogenetic tree from protein 
sequences of FC from a variety of organisms. Published NCBI or geneDB accession numbers and 
species name are shown for each sequence. Bootstrap values (1000 resamplings) are shown to the 
left of the relevant nodes. General phylogeny of clusters is shown to the right of the nodes. 
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Figure 2.5. Real time PCR of haem biosynthetic enzymes, ALAD and FC in all S. mansoni 
life-cycle stages. A) qPCR of ALAD. B) qPCR of FC. Mira, miracidia; T.sporo, mechanically 
transformed mother sporocysts; Cerc, cercariae; 4NSomu; mechanically transformed 
schistosomula cultured for 4 days in the absence of RBCs; 4RSomu, mechanically transformed 
schistosomula cultured for 4 days in the presence of RBCs. Error bars represent the standard error 
of means (n =  3). 
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2.3.4 Complementation assays of schistosomes ALAD and FC in mutant E. coli 
The complementation effects of the genes on the mutant E. coli are shown using solid phase medium 
(Figure 2.6) and liquid culture (Figure 2.7). In the complementation assay using mutant E. coli RP523 
strain, the E. coli ALAD genes demonstrated rescued growth of the mutant E. coli cultured in the 
absence of haem supplement in both solid and liquid phase media while the human ALAD genes 
appeared to have only partial complementation effect (Figure 2.6D and 2.10A). For mutant E. coli 
transformed with Sm-alad, the gene does not appear to rescue this growth deficiency.  
In the complementation assay involving the mutant E. coli VS200 strain, E. coli FC genes showed 
rescued growth of the mutant E. coli in both solid and liquid phase media. However, the human and 
schistosome FC genes do not show any complementation effect on the mutant E. coli with growth 
rate similar to that of empty pET21a+ vector in both solid and liquid culture (Figure 2.6 and 2.10B).  
2.3.5 Expression of recombinant schistosomes ALAD and FC proteins 
The recombinant SmALAD expressed in E. coli BL21 cells was purified from the soluble fraction 
using agarose-conjugated anti-T7 tag. The purified protein is confirmed by its molecular size 
(approximately 36kDa) and confirmed by Western blot using monoclonal T7 as primary antibodies 
(Figure 2.8A).  Protein production of SmFC in E. coli JM109 cells was purified from the membrane 
fraction using Ni-NTA. The purified protein is confirmed by its molecular size (approximately 
48kDa) and confirmed by Western blot using polyclonal anti-T7 as primary antibodies (Figure 2.8B). 
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Figure 2.6. Complementation assays of mutant E. coli cells in solid culture. Transformed E. 
coli cells grown in liquid medium prior to being sub-cultured onto LB agar plate. (A) LB agar plate 
supplemented with 20 µg haemin. (B) Schematic diagram of the agar plating arrangement. Mutant 
E. coli strains used (left) and the genes (right) inserted are as shown. pET21a+, empty pET21a+ 
vector; eAD, E. coli ALAD gene; hAD, human ALAD gene; sAD, S. mansoni ALAD gene; eFC, 
E. coli FC gene; hFC, human FC gene; sFC, S. mansoni FC gene. (C) LB agar plate containing no 
haemin after 24 hours incubation. 100µL of 100mM IPTG is spread on the plate prior to bacterial 
streaking. E. coli ALAD and FC cells showed growth after 24 hours. (D) LB agar plate containing 
no haemin after 48 hours incubation. Human ALAD cells showed growth (white arrow) after 
prolonged incubation (48 hours). 
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Figure 2.7. Complementation assays of mutant E. coli cells in liquid culture. Transformed E. 
coli cells were grown in LB medium containing 1M IPTG. The cells were cultured with shaking 
for 10 hours at 37oC and optical density (OD600) measured at intervals. (A) RP523 E. coli cells 
transformed with ALAD genes from human, E. coli and S. mansoni. E. coli ALAD cells entered 
logarithmic phase ahead of all cells after 3 hours incubation and human ALAD cells showed 
enhanced growth after 10 hours incubation (red arrow). (B) VS200 E. coli cells transformed with 
FC genes from human, E. coli and S. mansoni. E. coli FC cells showed exponential growth after 
3 hours incubation while all cells shown little or no growth. pET21a+, empty pET21a+ vector; 
eAD, E. coli ALAD gene; hAD, human ALAD gene; sAD, S. mansoni ALAD gene; eFC, E. coli 
FC gene; hFC, human FC gene; sFC, S. mansoni FC gene. Error bars represent the standard error 
of means (n=3) 
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2.3.6 Functional assay of schistosomes ALAD and FC proteins  
For ALAD and FC enzymatic assays, I expressed the recombinant human haem biosynthetic proteins 
as described in the above protocol and used them as positive control.  In this study, the Vmax and Km 
of human ALAD were 62.62 ± 3.5 µmol PBG/ mg protein.hour and 0.32 ± 0.013mM ALA 
respectively. For human FC, Vmax was measured as 24.7 ± 3.5 µmol Zn-PPIX/mg protein.hour while 
the Km was 0.29 ± 0.049µM PPIX. These results were found to be comparable with that of the enzyme 
activities of human ALAD reported in the studies by Wu et al. (2009) and yeast FC reported in the 
study by Camadro and Labbe (1988). Enzymatic assays for SmALAD and SmFC were performed at 
different pH, which range from 6.4 to 8.0 for ALAD and from 7.0 to 9.0 for FC. However, ALAD 
and FC activities were undetectable in the worm extracts and purified recombinant proteins. In order 
to check for the presence of inhibitors in crude worm extract, equal proportion of purified human 
biosynthetic enzymes were mixed with worm extract prior to initiate the enzymatic assay. The assay 
was performed in parallel with human proteins, which was also used as a comparison for any loss in 
enzyme activity. I found no difference in enzyme activity between the human control and that mixture 
containing worm extract.  
  
            
Figure 2.8: Purified schistosome haem biosynthetic enzymes proteins from E. coli. A) 
Recombinant SmALAD protein (36kDa, arrow) on SDS-PAGE gel (left) and Western blot (right). 
B) Recombinant SmFC protein (48kDa, arrow) on SDS-PAGE gel (left) and Western blot (right). 
Molecular weight markers in B (right) is the same as that in A (right).  All lanes were obtained 
from the same gel and are presented together for clarity.  
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2.4 Discussion 
De novo biosynthesis of haem has been highly conserved in most Archaea, bacteria and eukaryotes, 
especially the last seven of the eight steps of this pathway (Heinemann et al., 2008). While this 
pathway in mammals has been the subject of scrutiny for decades (Heinemann et al., 2008), 
knowledge of the presence of such pathways in parasitic organisms is limited. Studies in parasitic 
Protozoa have indicated that the pathway in different species is incomplete or defective (Chang et al., 
1975; Dutta et al., 2008; Padmanaban et al., 2007). So far, there has only been one study that looked 
at the presence of haem biosynthetic enzymes in schistosomes, in which it was suggested that these 
parasitic worms are incapable of synthesizing haem (Rao et al., 2005). However, all eight enzymes 
of the haem biosynthetic pathway were identified from EST databases of S. mansoni (Berriman et al., 
2009) and S. japonicum (Glanfield et al., 2007;Liu et al., 2006). In contrast to the conclusion by Rao 
and colleagues (2005), these putative genes indicate the presence of a fully functional haem 
biosynthetic pathway in schistosomes.  
S. mansoni ALAD and FC is expressed in all life-cycle stages that were investigated. The highest 
level of gene transcripts of Sm-alad occurred in the adult female worms and it is significantly higher 
compared with all other stages. As the adult female stage of schistosomes is associated with egg 
production, this high gene transcription may be correlated with strong requirement of haem to support 
embryogenesis and vitellogenesis.  While high gene transcription of Sm-fc was noted in the 
intramammalian stages of development, such as adults and mechanically transformed schistosomules, 
high level of Sm-fc transcripts was also detected in the mechanically transformed sporocysts. 
Interestingly, catabolism of host Hb and uptake of iron have also been noted to occur for this stage in 
the intermediate snail host, Biomphalaria glabrata (Lee and Cheng, 1972a, b). As ferrochelatase is 
primarily responsible for catalysing the insertion of Fe2+ into protoporphyrin IX to form haem 
(Heinemann et al., 2008), high transcription level of Sm-fc may be related to the abundance of easily 
available iron source in these stages. 
SmALAD shares approximately 56% amino acid identity with the human and mouse ALAD proteins. 
Protein structure prediction (see Figure 4A) indicated that SmALAD is likely to possess the 
characteristic TIM alpha/beta-barrel structure of protein belonging to the ALAD family (Erskine et 
al., 1997). Sequence alignments of SmALAD with ALAD proteins of human and mouse revealed 
conserved residues associated with enzymatic activity. Amino acid sequence of SmALAD also 
showed the presence of a cysteine-rich zinc binding motif and the determinant for an absence of an 
allosteric magnesium binding site (Kervinen et al., 2001), suggesting that SmALAD is a zinc-
dependent enzyme. Despite the high degree of structural homology between different ALADs, 
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considerable diversity in the use of metal ion cofactors has been observed (Heinemann et al., 2008; 
Jaffe, 2003, 2004). Interestingly, the presence of an active zinc binding site combined with the 
absence of an allosteric magnesium binding site is only documented in metazoan and fungal ALADs 
(Jaffe, 2003). In the ALAD phylogenetic tree, it appears that the schistosome ALADs are more 
closely related to the mammalian homologue than they are to bacterial enzymes. Thus, results of the 
in silico analysis indicate that SmALAD is a functional enzyme that is likely to be similar to 
mammalian ALADs.  
SmFC share approximately 53% and 54% amino acid identity with homologous proteins in human 
and mouse respectively.  Protein structure prediction (see Figure 2.1B) showed that SmFC are likely 
to possess two similar domains of a four stranded parallel beta-sheets flanked by alpha-helices, 
common to the FC enzymes from bacteria, plants and mammals (Al-Karadaghi et al., 1997). 
Sequence alignments of SmFC proteins with human and mouse FCs pinpointed conserved residues 
associated with enzymatic activity and a 30-residues region containing the distinctive iron-sulphur 
[2Fe-2S] cluster. This iron-sulphur cluster had been demonstrated to be a characteristic feature 
observed in mammalian FCs (Dailey et al., 1994; Ta and Vickery, 1992).  A unique 16-residues 
cluster, [[E/D]X2FXGVEXIX2PX3], was found to be conserved in FCs among all three trematodes 
examined here, S. mansoni, S. japonicum and C. sinensis and this domain was noted to be absent in 
other FC sequences investigated.  While I have no information whether such an amino acid cluster 
has any biological function, it will be useful to investigate if such clusters are also found in the haem 
biosynthetic enzymes of other trematodes, and other platyhelminth groups, including the Cestoda and 
Turbellaria.  Although phylogenetic analysis of SmFC showed that the schistosome FC enzymes are 
more closely related to the mammalian homologue than they are to bacterial enzymes, FC protein 
sequences from trematodes appear to form a clade distinctive from vertebrates. These results suggest 
that SmFC is likely to be a functional enzyme that shares similar biochemical characteristic with 
mammalian FCs.  
In the complementation assays, Sm-alad and Sm-fc were found to be incapable of rescuing the growth 
deficiency in the mutant E. coli. While this deficiency is complemented by E. coli genes, human 
genes also demonstrated a lack of efficiency in this rescue. In the study by Wu et al. (2009), they 
noted the rescue of RP523 mutant strain with human ALAD genes. Although I also noted a partial 
complementation effect by addition of the human, this effect is insignificant compared to that of E. 
coli genes in both liquid and solid media (see Figure 2.6 and 2.10). In contrast to work by Wu and 
colleagues (2009), I was unable to see any complementation effect from the human FC genes. A 
possible reason could be the co-transformation of RIL plasmid with the vector, which helps to 
overcome differences in codon usage between E. coli and human genes (Wu et al., 2009). This is seen 
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by the partial complementation effect observed in the human ALAD, using codon optimized 
sequences from Wu and colleagues (Wu et al., 2009). Another possibility could be attributed the 
different method used to verify the functionality of the genes. While my study measured the growth 
rate in the absence of haem, that of Wu and colleagues looked at the inhibition of the mutant VS200 
E. coli mutant strains by N-methyl mesoporphyrin IX (NMMP) complemented by the human and E. 
coli genes (Wu et al., 2009). Sequence analysis of SmALAD and SmFC suggest they are more closely 
related to mammalian than to bacterial genes. Thus, it is suggested here that this lack of demonstrable 
functionality of schistosome and human genes in mutant E. coli strains seen in my study is likely to 
be due to an incompatible enzymatic condition for eukaryotic haem biosynthetic protein in a bacterial 
system. Therefore, complementation using mutant yeast strain deficient in the haem biosynthetic 
pathway is likely to be an appropriate choice and will most likely provide a better understanding on 
the functionality of these two genes. However, due to time constraints, I was unable to perform this. 
No enzymatic activities were detected in recombinant SmALAD, SmFC proteins and crude worm 
extract. While this result is in agreement with the study by Rao et al. (2005), this contradicts the in 
silico analysis of the sequences. While the lack of biochemical activity in the crude worm extract 
could be due to contamination of the protein by nucleic acid, measurement of the worm extract ND-
1000 spectrophotometer did not reveal the typical nucleic peak at 260 nm. This indicates that the 
presence of nucleic is unlikely to contribute to this. The lack of activity for both proteins may also be 
due to the lack of post-translational modifications that are required for proper folding and stability of 
proteins (Frommer and Ninnemann, 1995; Lueking et al., 2000). This could also affect subsequent 
dimerization of the proteins, as human ALAD and FC have been found to exist as homo-octameric 
oligomers (Erskine et al., 1997) and homo-dimers (Al-Karadaghi et al., 1997), respectively in their 
active forms. Rapid loss of activity in Spirillum itersonii FC has been noted during the purification 
process (Dailey, 1977). Likewise, loss of activity may occur during purification of SmALAD and 
SmFC. Although the haem biosynthetic enzymes of human and other common model organisms, like 
S. cerevisiae and E. coli, have been well characterized, limited information are available for less 
studied organisms. Thus, the schistosome haem biosynthetic enzymes may have special requirements 
in order to be biologically active. This can be seen from reports showing restoration of activity upon 
addition of copper ions and crude lipid extract in S. itersonii (Dailey, 1977) , crude rat liver 
(Mazanowska et al., 1969) and avian ferrochelatase (Dailey, 1977).  
Although the addition of recombinant human ALAD and FC proteins to worm extract prior to the 
enzyme assay exclude the presence of inhibitors, the results should be treated with caution as it only 
exclude inhibitors that are specific to human and not S. mansoni ALAD and FC enzymes. In order to 
verify the functionality of the schistosome haem biosynthetic enzymes, the next step forward will be 
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to attempt to express the proteins in eukaryotic systems, such as yeast. Another approach would be 
to use a radioactive haem precursor (Braz et al., 1999) and verify if schistosomes are capable of 
incorporating these precursors to synthesize haem. While the use of inhibitors against haem 
biosynthetic enzymes in schistosomes, similar to the study performed by Bonday and colleagues 
(2000) on malaria, it should be noted that these haem biosynthetic enzymes may have different 
sensitivities to these inhibitors as compared to the human and bacterial enzymes (Wu et al., 2009).   
The loss of haem biosynthetic capabilities has been suggested as an evolutionary adaptation to 
haematophagy (Chang et al., 1975) and thus, identification of the ESTs of all eight enzymes of the 
haem biosynthetic pathway in the schistosome genomes (Callender et al., 1957; Liu et al., 2006) are 
suggestive that these proteins are important to the parasites. Thus, getting a better understanding of 
this pathway in schistosomes may provide potential drug targets against these parasites.  
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Chapter 3 - Haem uptake in Schistosoma mansoni 
3.1 Introduction 
Schistosomiasis is a water-borne disease caused by parasitic trematodes of the genus Schistosoma. 
Three species, namely Schistosoma mansoni, S. japonicum and S. haematobium, are responsible for 
most clinical cases (King et al., 2005; Sturrock, 1993). Schistosomiasis is one of the most prevalent 
parasitic infections worldwide, and is endemic in 74 developing countries, infecting over 200 million 
people (King et al., 2005). In addition, over 650 million people are at risk of infection (Steinmann et 
al., 2006).  
The need to salvage host haem is critical for haemoparasites, which possess a defective haem 
biosynthetic pathway (Gaughan and Krassner, 1971; Huynh et al., 2012; Lara et al., 2007). In 
Trypanosoma cruzi and Leishmania spp, the absolute nutritional requirement for haem to support 
growth and development is clearly evident (Gaughan and Krassner, 1971; Lara et al., 2007). However 
despite showing the presence of a functional haem biosynthetic pathway for Plasmodium 
(Padmanaban et al., 2007) and Rhodnius prolixus (Braz et al., 2001; Machado et al., 1998), studies 
in these parasites are suggestive of the uptake and salvaging of host haem. 
The demonstrated presence of numerous haemoproteins of importance, including cytochrome b and 
cytochrome oxidase (Coles, 1973; Glanfield et al., 2010; Liu et al., 2006; Saeed et al., 2002), 
highlights the importance of haem for schistosomes. Besides acting as an important co-factor, haem 
is also an easily available source of iron, an element that is abundant in adult schistosomes (Jones et 
al., 2007). In schistosomes, iron is required for parasite development and reproduction and is 
postulated to be essential for quinone-tanning of the schistosome eggshell (Jones et al., 2007). In 
humans, haem is postulated to be involved in the regulation of essential biological reaction including 
enzyme activation and cellular signal transduction (Hou et al., 2006; Ponka, 1999; Ye and Zhang, 
2004). These functions, and the role, if any, for haem has not yet not been investigated in 
schistosomes.  
Rao et al. (2005) concluded that schistosomes are incapable of de novo haem biosynthesis based on 
enzymatic studies of S. mansoni. Currently, there is limited information about haem biosynthesis and 
uptake in schistosomes. Since haem is an essential nutrient for schistosomes, understanding this 
metabolic pathway could provide potential drug targets for the control of this disease. Thus, in this 
study, I aim to verify if schistosomes salvage and take up host haem to support their nutritional needs 
through the use of a fluorescent haem analogue, palladium mesoporphyrin IX (Pd-mP). 
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3.2 Materials and methods 
3.2.1 Isolation and culture of parasites   
Adult S. mansoni (Puerto Rican strain) worms were perfused with pre-warmed (37oC) Gibco® RPMI 
1640 (Life Technologies, Germany) from female ARC Swiss mice 6-8 weeks after percutaneous 
challenge with cercariae shed from Biomphalaria glabrata snails. Freshly perfused worm pairs were 
washed with warm RPMI and cultured in Dulbecco’s modified Eagle medium (DMEM) (Life 
Technologies, Germany) containing 200 U/mL Penicillin-streptomycin (Life Technologies, 
Germany) and 10% Foetal Bovine Serum (FBS) (Life Technologies, Germany) and incubated at 37oC 
in the presence of 5% CO2.   
3.2.2 Fluorescent haem analagoues preparation  
Palladium mesoporphyrin IX (Pd-mP) (Frontier Scientific, USA) and haem (Sigma-Aldrich, USA) 
stock were prepared in dimethyl sulfoxide (DMSO) to a concentration of 200 mM and diluted to 100 
mM in 0.1 M NaOH prior to use. Human albumin conjugated to Texas Red (HSA-TR) (Rockland 
Immunochemicals, USA) was reconstituted in sterile deionized water to a concentration of 1mg/mL. 
A stock solution of Rhodamine B (Sigma-Aldrich, USA) was prepared as 100 mM dissolved in 
ethanol.   
In order to obtain an equivalent fluorescent analogue of haemoglobin (Hb), palladium mesoporphyrin 
IX globin (Pd-mP-globin) was prepared as described (Lara et al., 2005; Teale, 1959). The globin 
solution was prepared as follows: human Hb, a concentration of 20 g/L, was dissolved in water. A 
one-fifth volume of 0.1M hydrochloric acid (HCl) was added, acidifying the solution to pH of 2.0. 
The acidified solution was incubated on ice for 2 min. Next, an equal volume of ice-cold 
methylethylketone (MEK) (Sigma-Aldrich, USA) was added to separate protein and haem into two 
liquid phases. The ketonic supernatant (containing the haem) was removed, leaving the lower phase, 
which is the globin solution. The globin protein was washed and renaturated by sequential dialysis 
against water. Pd-mP was added to the refolded protein at a final concentration of 100 mmol/L and a 
new dialysis against water was used to remove unbound Pd-mP. The Pd-mP-globin solution is 
centrifuged at 12,000 × g and the supernatant was filtered using 0.22 µm pore size membrane and 
stored at 4oC for one week. 
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3.2.3 Determination of spectral characteristic of haem analogues and controls  
The fluorescence characteristics of Palladium mesoporphyrin IX (Pd-mP) have been observed and 
determined by Lara et al. (2005), in a study where Pd-mP was used as a haem analogue to investigate 
the uptake of haem in Boophilus microplus. Emission wavelength, over the range of 500 to 700 nm, 
and intensity of bound and free Pd-mP and controls, which include haem and Hb, were measured at 
an excitation wavelength of 400 nm. HSA-TR, was measured at an excitation wavelength of 480 nm 
while rhodamine B was measured at an excitation wavelength of 510 nm. All measurements were 
performed using Biotek Synergy H4 multi-mode plate reader (Life Technologies, Germany). 
3.2.4 Pulse chase experiment 
Freshly perfused adult worm pairs were initially incubated with DMEM medium containing 100 µM 
Pd-mP for different time intervals (5, 15, 30, 60, 120 min and overnight) at 37oC, 5% CO2 to 
investigate how long it takes for the worm to completely take up Pd-mP into its system. As 
fluorescence of Pd-mP can be detected in the worms after 60 min incubation, the incubation 
conditions were set up as follow: worms were cultured in medium containing 100 µM Pd-mP (or 
control fluorophore) for two hours, followed by a replacement of the original culture medium with a 
new medium containing 100 µM haem in place of Pd-mP (or control fluorophore) for another one 
hour. Adult parasites cultured in the presence of haem, Hb, HSA-TR and rhodamine B were used as 
negative controls. The worms were then fixed in 100% methanol and washed three times in 1xPBS.  
The  worms were soaked overnight in ScaleA2 (4 M urea, 10% (w/v) glycerol, 0.1% (w/v) Triton X-
100) (Hama et al., 2011) to clarify worm structures, before being mounted onto slides in a 1:1 mixture 
of PBS : glycerol. 
3.2.5 Inhibitor assay using cyclosporin A   
Pulse chase experiment after Cyclosporin A (CsA) treatment. In mammals, multiple ATP-binding 
cassette (ABC) transporters, which include the ATP-binding cassette subgroup B member 6 (ABCB6) 
(Krishnamurthy et al., 2007) and the ATP-binding cassette subgroup G member 2 (ABCG2) 
(Krishnamurthy et al., 2006), have identified as being capable of mediating the transmembrane 
transfer of haem or porphyrin. As such, it is possible that this uptake of haem in schistosomes is 
mediated by an ABC transporter. In order to investigate this possibility, we decided to treat adult 
schistosome worms with CsA and see if it has any effect on haem uptake in the parasites. To do so, 
perfused adult schistosome worms were pre-incubated in different concentration of CsA before 
performing the pulse chase experiment using Pd-mP. CsA was dissolved in DMSO for stock solution 
and diluted 1:1 into Cremophor-EL (Sigma-Aldrich, USA) at the appropriate concentration in culture 
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medium. Freshly perfused adult worm pairs were pre-incubated for 2 hours in culture medium 
containing 10 µM or 100 µM CsA. Worms used as positive control were pre-incubated in DMSO 
instead. Next, a pulse chase experiment using Pd-mP was performed as described above (section 
3.2.4) except that the culture medium contained the respective concentration of CsA given during 
pre-incubation. For this study, three separate experiments were performed using 3-6 worm pairs per 
group during each experiment. 
Egg counts and morphology. In order to determine the effect of CsA on egg maturation, a 
classification chart was created using VectaShield DAPI (4’6-diamidino-2-phenylindole) mounting 
media (Vector Labs, USA) nuclei staining on S. mansoni eggs, as seen in the work by You et al. 
(2012) for S. japonicum. I grouped the eggs into five distinct stages, as seen in Figure 3.1 – stage I 
(Figure 3.1A), stage II (Figure 3.1B), stage III (Figure 3.1C), stage IV (Figure 3.1D) and stage V 
(Figure 3.1E). Worms treated with DMSO and CsA (10 µM or 100 µM) were placed in individual 
wells of a 96-well plate containing one worm pair per well and maintained in the culture medium 
containing 10% FBS and maintained at 37oC, 5% CO2 for 72 hours. Next, the cumulative egg 
produced by the control and treated worms were counted. The eggs produced were collected by 
centrifugation (500 x g, 5 min) and fixed in 100% methanol for 8-10 min. After this, the eggs were 
incubated in DAPI stain overnight at 4oC and the images were captured using the DeltaVision® RT 
imaging microscope (GE Healthcare, Sweden).   
3.2.5 Imaging and statistics  
Imaging. All mounted worms in the pulse chase experiments were subjected to excitation at 390 nm 
(DAPI filter) and images were captured using a Cy5 filter (676nm) and TRITC filter (594 nm). 
Additional image captures were performed for parasites incubated in HSA-TR (excitation/emission: 
FITC/TRITC (525/594 nm)) and Rhodamine B (excitation/emission: FITC/TRITC (554/627 nm)). 
The DAPI-stained eggs were subjected to excitation at DAPI (381-399nm) and images were captured 
at DAPI (435/48nm). All images were visualised and captured using a DeltaVision® RT imaging 
microscope at an exposure of 0.15 sec and neutral density (%T) of 10%. All images are equally 
processed by Applied Precision softWoRx® Suite version 1.3 (GE Healthcare, Sweden) and ImageJ 
(Schneider et al., 2012).  
Quantitative determination of Pd-mP uptake. For all images taken using DeltaVision® RT imaging 
microscope, the emission intensity value of each point on the images was captured during the process 
and these values from the raw images were obtained on Applied Precision softWoRx® Suite version 
1.3. As the uptake of Pd-mP was most distinct in the ovary, the point in the ovary with highest 
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emission intensity value at Cy5 was used as representative value of each adult worm imaged. This 
value was tabulated among all treatment groups and used as a quantitative determination of Pd-mP 
uptake in S. mansoni.  
Statistics. Data were expressed as mean ± standard error of means (SEM), and were tested for 
statistical significance using ANOVA or unpaired t-test. This is performed using GraphPad Prism 
6.02 for Windows (GraphPad Software, USA). 
3.3 Results 
3.3.1 Spectral characteristic of haem analogues and controls  
In my study, I used palladium mesoporphyrin IX (Pd-mP) to investigate haem uptake in tissues of 
Schistosoma mansoni. I observed a weak green emission peak for free Pd-mP (Figure 3.2A) and a 
distinct high intensity red emission peak of 665nm for Pd-mP bound to globin (Figure 3.2B, red 
arrow) after excitation at 400 nm, confirming the analysis by Lara et al. (2005). The spectral 
characteristic of the fluorescence controls, which include human serum albumin bound to Texas-Red 
 
Figure 3.1. Staging of S. mansoni egg development. Blue fluorescent DAPI was used to classify 
the five developmental stages based on the size of the egg and the density and arrangement of the 
stained nuclei as shown in A-E. Stage I (A), egg is small (63 uM) and nuclei are few (6-12) and 
less compact; stage II (B), egg is bigger (111 uM) and nuclei are numerous and denser; stage III 
(C), nuclei occupy most of egg interior; stage IV (D), nuclei condensed into a large mass around 
centre of egg; stage V (E), nuclei formed a distinct ring shape. 
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(HSA-TR) and Rhodamine B, were measured and shown in Figure 3.2C and D. It can be seen that 
HSA-TR showed a distinct peak at around 610 nm after excitation at 480 nm while rhodamine B 
showed a distinct peak at around 580 nm after excitation at 510 nm. 
3.3.2 Pulse chase experiment  
In the pulse chase experiment, green autofluorescence was seen in the vitelline region of control 
worms cultured in medium containing one of haem, Hb, HSA-TR or Rhodamine B (Figure 3.3A-D). 
For worms cultured in Pd-mP, when the worms were imaged in the far red, the ovary and vitelline 
region appeared red. This, together with the green autofluorescence of the vitelline, overlay images 
of the far red and green showed yellow fluorescence in the vitelline region of female worms cultured 
in Pd-mP.   Significantly, the ovary of worms cultured in medium containing Pd-mP also displayed a 
distinct red fluorescence (Figure 3.3E-F, white arrows), not observed in the control worms (haem 
(green arrow), HSA-TR (blue arrow), Hb (yellow arrow) or Rhodamine B (red arrow) (Figure 3.3A-
D). 
Figure 3.2. Spectral characteristic of palladium mesoporphyrin IX and fluorescence 
controls. Spectra of free palladium mesoporphyrin IX (Pd-mP) (A) and bound Pd-mP (B) of 
concentration of 100nM after excitation at 400nm. Spectra of human serum albumin bound to 
Texas-Red (HSA-TR), concentration of 100nm, after excitation at 480nm and Rhodamine B, 
concentration of 0.1nM, after excitation at 510nm.  Abbreviation: HSA-TR – human serum 
albumin – Texas Red. 
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3.3.3 Inhibitor assay using cyclosporin A 
Pulse chase experiment after CsA treatment. My results showed that CsA inhibits the uptake of Pd-
mP by ovarian and vitelline tissues and this effect is concentration dependent. This was demonstrated 
both qualitatively (Figure 3.4) and quantitatively (Figure 3.5A).  
Egg count and morphology. For adult female worms treated with CsA, I observed CsA result in a 
drop in egg production (Figure 3.5B) as well as a delay in egg maturation (Figure 3.5C).  
 
Figure 3.3. Pulse chase experiments. Worms were first incubated in medium containing the Pd-
mP (100 µm) or the control fluorophores for two hours, followed by a replacement of the culture 
medium containing 100 µM haem for another one hour. The treated worms were mounted and 
images were captured using DeltaVision® RT imaging microscope after excitation Merged 
fluorescence (top or left) and brightfield (bottom or right) stitched images of mounted female worm 
cultured in the presence of haem (A), HSA-TR (B), Hb (C), rhodamine B (D) and Pd-mP (E). Note 
the green autofluorescence of the vitelline region of controls (A-D) and the yellow fluorescence of 
vitelline cell of worm in Pd-mP (E). Worms cultured in the presence of Pd-mP (E-F) also showed 
an intense red fluorescence in the ovary region (as pointed by the white arrows) at 10x (E) and 40x 
(F) images while control worms cultured in haem (green arrow), HSA-TR (blue arrow), Hb (yellow 
arrow) or Rhodamine B (red arrow) showed lack of fluorescence in the ovary region.  Abbreviations: 
O – ovary; V - vitelline 
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Figure 3.4. Pulse chase experiment after CsA treatment. Overlapping fluorescence and optical 
stitched images of mounted adult female worm pre-cultured in 0µM (Fig A & D), 10 µM (Fig B & 
E) or 100 µM CsA (Fig C & F) before performing pulse chase experiment using Pd-mP. Note the 
accumulation of Pd-mP (red fluorescence, white arrows) for worm not treated with CsA (Fig A & 
D) and the decreasing intensity (Fig B-F) for worms treated with increasing concentration of CsA. 
Abbreviations: O – ovary; V - vitelline 
 
Figure 3.5. Emission intensity of ovary and egg counts and morphology after CsA treatment. 
A) Highest emission intensity of the ovary of images taken at 20x was recorded and tabulated. The 
chart compares the emission intensity of the ovary between all treatment groups. B) Chart shows 
the eggs produced per worm pairs after 72 hours incubation. C) Chart shows the ratio of the 
different development stages of egg laid by adult female treated with CsA after 72 hours 
incubation. Error bars indicate the standard error of means (SEM) of the biological replicates. For 
(C), n = 3. 
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3.4 Discussion 
In schistosomes, catabolism of host erythrocytes generates massive quantities of haem. While haem 
has been demonstrated as a potentially toxic pro-oxidant and is rapidly egested from the gut of 
schistosomes as haemozoin (Oliveira et al., 2000a), there has been growing evidence that haem is 
more than a metabolic by-product for many blood borne parasites (Machado et al., 1998; Sun et al., 
2013; Zhou et al., 2007). In schistosomes, an early study by Foster and Bogitsh (1986), suggested 
that schistosome schistosomula actively utilize the haem components of host Hb. Subsequent to this, 
evidence has been more circumstantial. In two studies, it has been observed that there is an up-
regulation of protein associated with schistosome ferritin, an iron storage protein, with blood feeding 
(Gobert et al., 2010; Sun et al., 2013).  This indicates the need for host haem as an important iron 
source in schistosomes (Gobert et al., 2010; Sun et al., 2013). I present here, in support of the study 
by Foster and Bogitsh (1986), evidence to suggest that schistosomes do take up exogenous haem to 
support their nutritional needs.  Furthermore, I demonstrated that the fluorescent haem analogue, Pd-
mP, is accumulated in reproductive and gonadal tissues of females, the vitelline glands and ovary.  
The presence of the analogue in the tissues associated with egg formation may indicate that haem has 
a role to play in embryogenesis and vitellogenesis and embryogenesis, and is thus a likely determinant 
of fecundity. This observation is in line with other studies that suggested that haem is an important 
nutrient requirement supporting embryogenesis in many blood feeding parasites (Machado et al., 
1998; Sun et al., 2013; Zhou et al., 2007).    
Although the Pd-mP is structurally similar to that of haem, the replacement of the metal ion within 
the porphyrin from iron to palladium, led us to question if these two molecules possess varying 
biochemical properties. In a trial experiment with worms cultured in medium containing both haem 
and Pd-mP, a decrease in fluorescence intensity was noted only when the concentration of haem was 
equal or higher than that of Pd-mP used (results not shown). This lent credibility of the use of Pd-mP 
as haem analogue in the pulse-chase experiment. Since Pd-mP may not be transported as efficiently 
as haem, the use of other fluorescent porphyrins using Zn or Sn or radiolabeled haem in these pulse-
chase experiment would be useful in understanding this transmembrane uptake of haem in 
schistosomes. 
In my study, I was unable to determine the precise cellular location of Pd-mP in the ovary, although 
it was noted all parts of this organ fluoresced.  Although I understand the importance of getting image 
and analysis of the treated worms at high magnification and tried to image the worms using confocal 
microscopy, I was unable to do it due to technical difficulties in setting the right excitation wavelength 
using the confocal microscopy in the research institute. Ultrastructural investigation of the ovary, 
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indicated that the ovary contains only oocytes in various stages of maturation (Gobert et al., 2009).  
Thus the likely cells that accumulates the analogue are the oocytes, regardless of their stage of 
maturation.  Similarly, the vitelline follicles are enriched with vitellocytes (Gobert et al., 2009), and 
likewise these cells are the mostly likely target in the pulse chase experiment.  One would expect that 
eggs would thus be enriched for haem, since the component precursor cells of the eggs accumulate 
the analogue.  Eggs did not fluorescence in the pulse chase studies, but this absence of label might be 
most likely due to the impervious nature of the egg shell, or lack of transport pathways in the uterine 
epithelia.  
Although it has been demonstrated that transmembrane transfer of haem is possible through passive 
diffusion, it is thought that this process is too slow for biological processes (Light and Olson, 1990). 
Thus, I was interested to explore if this uptake and accumulation of haem (MW: 651.94) or Pd-mP 
(MW: 699.127) is mediated by non-specific binding for small molecules and Rhodamine B (MW: 
479.02) was used as control for this. Another control, HSA-TR, was used as control, as host albumin 
has been shown to be ingested and accumulated within the oesophagus and caecum of juvenile and 
adult worms (Holtfreter et al., 2010). This allows us to understand if this uptake of haem in 
schistosomes is mediated by a similar pathway for albumin since Hb and albumin are the most 
abundantly available proteins in human blood (Whitfield, 1979). The absence of detectable 
fluorescence in the ovary for worms cultured in medium containing rhodamine B and HSA-TR as 
compared to that in Pd-mP indicates that the transmembrane uptake of haem in schistosomes is likely 
to be an active process that is specific to haem or porphyrins (Light and Olson, 1990; Shayeghi et al., 
2005). 
An anti-schistosome effect of CsA was first reported by Bueding et al. (1981) and subsequent 
confirmed in further studies (Bout et al., 1984; Kasinathan et al., 2011; Munro and McLaren, 1990). 
However, the exact mechanism is still unknown and there have been various speculations on how 
CsA affects schistosomes (Bout et al., 1984; Guorlay et al., 2007; Kasinathan et al., 2011; Munro 
and McLaren, 1990), with the P-glycoprotein (P-gp) (an ATP-binding cassette (ABC) transporter) 
(Kasinathan et al., 2011) and S. mansoni cyclophilin A (Guorlay et al., 2007) suggested as potential 
parasite target for CsA. In my study, I demonstrated that CsA inhibits the uptake of Pd-mP by the 
ovary of S. mansoni in concentration-dependent manner. Similar to the work by Kasinathan et al. 
(2011), I showed that CsA disrupted egg production in schistosomes. Furthermore, I also found that 
worms treated with CsA also produce eggs that show delay in development and maturation. As CsA 
is a potent inhibitor of transporter proteins belonging to ATP-binding cassette (ABC) transporter 
family (Sharom, 2008), it is possible that this transmembrane transport of haem in schistosomes is 
mediated by ABC transporter proteins. Although I observed a concentration-dependent effect of CsA 
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on the inhibition of haem uptake, increasing concentrations of the drug did not result in significant 
difference in egg production and maturation in CsA-treated worms. This suggests that while the 
schistosome protein involved in transmembrane transport of haem is like a primary target of CsA, the 
inhibitory action of CsA on haem uptake may not fully account for the anti-fecundity effect of CsA 
on S. mansoni noted by us as well as Kasinathan et al. (2011). This is not surprising findings since 
CsA is suggested to target multiple schistosome proteins (Khattab et al., 1998; Serra et al., 1999).  
The evidence here shows accumulation of bound Pd-mP in the female germinal tissues.  There was 
no fluorescence in other tissues, including the tegument or gastrodermis.  This lack of fluorescence 
in those tissues could be due to a number of reasons.  The uptake of bound Pd-mP across these barriers 
may be rapid and below the resolving power of the microscopes, which were used to image whole 
worms at low resolution.  Alternatively the haem analogue molecules may be stripped from its 
component protein in the caeca of the worms and lose their fluorescence, regaining it only when they 
are bound in the gonadal tissues.  The presence of fluorescence in the ovary suggests, at least, the 
presence of haem transporters in the female gonadal tissues.   
While haem has long been considered as a metabolic waste product of RBC breakdown, an increasing 
number of findings are now suggesting that host haem is an important nutrient for schistosomes and 
other blood parasites (Machado et al., 1998; Sun et al., 2013; Zhou et al., 2007). In addition, haem is 
also known to serve as important source of iron in other organisms (Callender et al., 1957; Zhou et 
al., 2007) and iron in schistosomes is thought to be required for egg-shell formation and vitellogenesis 
(Jones et al., 2007). As such, I present evidence to show that haem uptake and metabolism is an 
essential biological process that supports reproduction in schistosomes.  
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 Chapter 4 – Characterization of a haem transporter of Schistosoma mansoni 
4.1 Introduction 
While researchers have viewed the haem detoxification as an important aspect of survival for many 
haemoparasites (Bonday et al., 1997; Oliveira et al., 2000a; Oliveira et al., 2003), increasing evidence 
is now supporting the premise that these haemoparasites also salvage host haem to support their 
growth and reproduction (Ohagan, 1974; Sun et al., 2013; Zhou et al., 2007). Oliveira et al. (2000a) 
indicated that for schistosomes, not all haem generated by haemoglobin catabolism is polymerized 
into haemozoin (Hz). These authors contended that up to 50% of the digested total haem in females 
and 10% in males was converted into haem. While this observation could indicate the presence of an 
alternative detoxification mechanism, it might also suggest that uptake of host haem is also occurring 
in schistosomes.  
My results from the previous chapter, together with the study by Foster and Bogitsh (1986), confirmed 
the presence of a haem uptake system in S. mansoni.  While the salvage of exogenous haem in 
schistosomes could serve as a mechanism to supplement the porphyrin needs of the parasite, the role 
of haem as an important source of iron cannot be disregarded (Glanfield et al., 2007). The high levels 
of iron in adult female worms and parasite eggs (Jones et al., 2007) reflects high level requirements 
that may not be fulfilled solely by host transferrin and non-transferrin-bound iron (Glanfield et al., 
2007). This is further supported by the reported associated up-regulation of schistosome ferritin, an 
iron storage protein, in parasites cultured in the presence of red blood cells (RBCs) (Gobert et al., 
2010). 
Haem is an iron-containing tetrapyrrole that is capable of binding and reacting with lipid, protein and 
DNA (Ponka, 1999; Toh et al., 2010). Although it has been demonstrated that transmembrane transfer 
of haem is possible through passive diffusion, it is thought that this process is too slow to efficiently 
support biological processes (Light and Olson, 1990). Furthermore, the reactive nature of haem 
underlines the need for a detoxification mechanism that prevents and protects against haem-mediated 
damage during this transfer (Toh et al., 2010). As such, transmembrane transport of haem is likely to 
be facilitated by the presence of a receptor or transporter protein (Light and Olson, 1990; Shayeghi 
et al., 2005).  
In Caenorhahditis elegans, two proteins, the haem responsive genes-1 and -4 (HRG-1; HRG-4) and 
have been identified as potential haem transporter proteins as they were found to be highly up-
regulated in the presence of low haem environment and were predicted to possess transmembrane 
domains (TMDs) and putative transporter function (Rajagopal et al., 2008). Subsequently, orthologs 
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to the HRG-1 proteins have been identified and characterized in other organisms, including 
Leishmania, human and the zebrafish (O'Callaghan et al., 2010; Khan and Quigley, 2013; Huynh et 
al., 2012; Rajagopal et al., 2008; Yanatori et al., 2010; Yuan et al., 2012).  These proteins possess 
four TMDs, despite sharing low amino acid identity ( ̴ 20%).  Together, the proteins  have been widely 
defined as HRG-1 or solute carrier 48 subgroup A member 1 (SLC48A1) (Khan and Quigley, 2013).  
In searching for potential haem transporters for schistosomes, I hypothesized that such transporter 
protein may also exist in schistosomes.  
The involvement of such membrane-associated molecule(s) in the uptake of haem in schistosomes is 
unknown. As nutrient acquisition is integral to survival of schistosomes in the host (Whitfield, 1979), 
I hypothesise that characterisation of such molecule could provide better understanding of haem 
metabolism in schistosomes and reveal potential targets for drug and vaccine development.  
4.2 Materials and method 
4.2.1 Sequence analysis and phylogeny 
A BLASTP search for homologues of C. elegans haem-responsive gene-4 (HRG-4), a known haem 
transporter protein, in the S. mansoni genome databases, SchistoDB 
(http://www.genedb.org/Homepage/Smansoni), yielded an unknown gene, Smp_155760 (Logan-
Klumpler et al., 2011). This gene was predicted to translate into a 148 amino acids protein and the 
predicted protein shared homology of 29% and 20% with the HRG-1 protein (NP_956300) in 
zebrafish and HRG-4 protein (CAQ58110) in C. elegans.  Thus, I defined this gene as a putative S. 
mansoni haem responsive gene-1 (SmHRG-1).  
The protein profile of SmHRG-1 was analysed using the PredictProtein server to predict the presence 
of transmembrane domains (Rost et al., 2004) while the membrane spanning regions and their 
orientation was predicted using TOPCONS (consensus prediction of membrane protein)  (Bernsel et 
al., 2009) and presented pictorially using TOPO2 (John, 1996). Phylogenetic analysis of SmHRG-1 
was performed using a minimum evolution tree as described for studies of schistosome ALAD and 
FC in Chapter 2 (section 2.2.3).  
4.2.2 Real-time PCR 
Preparation of individual stages of S. mansoni life-cycle was as described in Chapter 2 (sections 
2.2.1). Isolation of total RNA from the parasite materials and synthesis of complementary DNA were 
explained in Section 2.2.2. Complementary DNA (cDNA) of gastrodermis, ovary and vitelline tissues 
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(courtesy of Dr Sujeevi Nawaratna, QIMRB) were obtained through laser microdissection of adult 
schistosome tissues (Nawaratna et al., 2011a). In brief, the tissues were micro-dissected and collected 
from toluidine blue-stained cryo-sections of S. mansoni female adult worms using a PALM 
Microbeam laser catapult microscope (P.A.L.M. Microlaser Technologies) and cDNA were 
synthesized from RNA extracted from these tissues as described (Nawaratna et al., 2011b). 
Differential expression of Smhrg-1 in all the life-cycle stages and three micro-dissected tissues of S. 
mansoni were followed as detailed in section 2.2.4. Forward and reverse primers (Sigma-Aldrich, 
USA) were designed from unique sequences of the Smhrg-1 coding region to amplify a region of 148 
bp (Table 4.1). 
4.2.3 Gene product knock-down studies using RNA interference 
To check for potential knock-down of genes other than those specifically targeted (off-targets), full 
length sequences of Smhrg-1 CDS was searched using the BLASTN function, with a relaxed E value 
of 1000, on SchistoDB (http://www.genedb.org/Homepage/Smansoni) for gene segments of 18 
nucleotides or longer that contained 100% identity to another protein. Template Smhrg-1 was 
amplified from S. mansoni whole female cDNA using forward and reverse primers (Table 4.1) that 
included the T7 RNA polymerase promoter sequence. Firefly luciferase plasmid was kindly provided 
by Dr Mai Tran (QIMRB) and served as the negative control (Tran et al., 2010). Double stranded 
RNA (dsRNA) was synthesized from the target DNA using Ambion T7 MEGAscript ® RNAi kit 
(Life Technologies, Germany) according to the manufacturer’s instructions.  
 
Infected female ARC Swiss mice were perfused and washed with warm (37oC) RPMI medium to 
obtain adult parasites (6 weeks post cercarial challenge).  The parasites were cultured in 1mL DMEM 
supplemented with 10% FBS and 200 U/mL Penicillin-streptomycin in 24-well tissue culture plates. 
Groups of six adult worm pairs were cultured at 37oC under 5% CO2 atmosphere. After 48 hours, the 
worms were placed in a 0.4 Gene Pulser® cuvette (Bio-Rad, USA) with 50 µL electroporation buffer 
(150 mM sucrose, 27 mM Na2HPO4, pH 7.5) containing 2 µg of Smhrg-1 or luciferase dsRNA and 
electroporated using the BIO-RAD GenePulser Xcell CE electroporation apparatus (Bio-Rad, USA) 
with a single pulse square wave at 125 V, 20 ms. Electroporated worms were cultured for 72 hours 
with media changes every second day. The worms were homogenized in TRIZOL for RNA 
Subsequently, cDNA for each group was synthesized using the SuperScriptTM III reverse 
transcriptase (Life Technologies, Germany) according to the manufacturer’s instructions. Real-time 
PCR was performed on all samples as described above. Percentage inhibition of mRNA for a specific 
gene was calculated by comparing the copy number of the gene in the parasites given the targeted 
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dsRNA to the of the group electroporated with the firefly luciferase dsRNA using the Rotor Gene 6 
software. Next, the treated worm pairs were placed in individual wells of a 96-well plate containing 
one worm pair per well and maintained in the culture medium containing 10% FBS and maintained 
at 37oC, 5% CO2 for 72 hours. 
 
In order to determine if SmHRG-1 mediates uptake of haem in the ovary, worms treated with dsRNA 
were subjected to a pulse chase experiment, as described in Chapter 3 (section 3.2.4).  The cumulative 
eggs produced by the treated worms and by luciferase-treated controls were counted after incubation 
for 72 hours and subsequent processing of the eggs was performed as detailed in section 3.2.5. For 
this study, three separate experiments were performed using six worm pairs per group during each 
experiment. 
 
Visualisation and imaging of all treated worms and eggs followed methods as outlined in section 
3.2.6. Data were expressed as mean ± SEM, and were tested for statistical significance using one way 
ANOVA or unpaired t-test, using GraphPad Prism 6.02.  
4.2.4 Functional expression of schistosome HRG-1 cDNAs in yeast 
All experiments were carried out using the HEM1∆ yeast strain (BY4743 Mat a/α his3∆1/ 
his3∆1 leu2∆0/ leu2∆0 lys2∆0/LYS2 MET15/ met15∆0 ura3∆0/ura3∆0) which was obtained from 
the European Saccharomyces cerevisiae Archive for Functional Analysis (http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/index.html). The yeast mutant strain, HEM1∆, is defective in the 
first step of haem biosynthesis pathway and is unable to synthesize haem (Gollub et al., 1977). This 
deficient yeast strain grows poorly on media that is not supplemented with additional δ-
aminolevulinic acid (ALA).  
 
The Smhrg-1 gene was amplified from S. mansoni adult worms and the Cehrg-4 gene was amplified 
from wild type C. elegans strain N2, which was a generous gift from A/Prof Paul Ebert (University 
of Queensland). The NotI restriction recognition site was added to all forward and reverse primers 
(Table 4.1). For the cloning of the C. elegans hrg-4 and S. mansoni hrg-1 genes into pFL61 vector, 
they were sent for commercial cloning (Bioneer, USA). In brief, the pFL61 vector contains ampicillin 
resistance and URA3 genes, which allow selection of the plasmid after E. coli and S. cerevisiae 
transformation respectively (Minet et al., 1992). The genes were cloned into the NotI site of the pFL61 
vector in the direction of PGK 5’ to PGK 3’. The vectors containing Smhrg-1 and hrg-4 were 
sequenced at a concentration of ¼ reactions using Big Dye 3.1 in QIMR Berghofer sequencing facility 
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using pFL61 forward primer GTTTTCAAGTTCTTAGATGC and pFL61 reverse primer 
AGCGTAAAGGATGGGG. This was to verify insert sequence and orientation prior to 
transformation into the mutant yeast strain.  
 
Transformation of the plasmids into HEM1∆ yeast was performed by lithium acetate transformation 
as described previously with 5 µg of plasmid used for each transformation. Transformed yeast 
colonies were selected on synthetic defined (SD) minus (2% (W/V) nitrogen base containing 2% 
(W/V) dextrose (Sigma-Aldrich, USA) media supplemented with appropriate amino acid 
requirements (histidine, leucine, lysine and methionine) in the absence of uracil and cultured at 30oC 
for 2-5 days. As the yeast mutant strain, HEM1∆, is defective in the biosynthesis of ALA Gollub et 
al., 1977), the precursor of haem, 50 µM ALA was added to enhance growth of the mutant yeast 
strain.  
 
In addition to being inefficient in taking up exogenous haem (Protchenko et al., 2006), the S. 
cerevisiae HEM1∆ strain is also defective in the de novo biosynthesis of haem (Gollub et al., 1977). 
This allows us to verify if SmHRG-1 are capable of support growth of the mutant HEM1∆ yeast strain 
by mediating the uptake of exogenous haem from the environment. In the initial haem 
complementation assays, experiments were performed using the standard SD minus media, which 
contained 2% (W/V) dextrose. However, growth was observed in all solid phase regardless of the 
concentration of haemin used. Furthermore, growth in the liquid culture showed better growth of the 
yeast cell transformed with empty pFL61 vector as compared to Smhrg-1 and C. elegans hrg-4 cells. 
As such, the dextrose in the SD minus medium was replaced with glycerol. However, due to the 
glycerol based medium being a poor yeast culture medium (Swinnen et al., 2013), the mutant yeast 
cell grew poorly during the complementation assay. In order to circumvent this problem, minute 
quantities (approximately 0.2% (W/V)) of dextrose were added to the media to enhance cell growth.  
 
Haem complementation experiments were carried as described with modifications (Bzducha-Wróbel 
et al., 2013; Huynh et al., 2012). Briefly, four to five transformed yeast colonies were picked and re-
streaked on SD minus-glycerol (0.67% (W/V) nitrogen base without amino acid, 6% (V/V) glycerol, 
0.2% (W/V) dextrose, pH 4.0) plate supplemented with appropriate amino acid requirement and 250 
µM ALA. Prior to spotting, the cells were cultured overnight in SD minus-glycerol media containing 
the appropriate amino acid requirement but with no ALA supplemented to deplete haemin. Next, the 
cells were pelleted and resuspended in water to an OD600 of 1.0 and serially diluted. Three microliters 
were spotted onto SD minus-glycerol media plates containing 0.1, 0.25, 1 and 20 µM haemin. Plates 
were then incubated for 5 days at 30oC and photographed. 
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For the liquid phase of the complementation assay, the cells were prepared as described above. Next, 
50 mL flasks of fresh SD minus-glycerol media, containing 1 µM haemin, were spiked with 100 µL 
of starter culture (OD600 of 1.0). Flasks were cultured for 48 hours, with shaking (230 rpm) at 30oC. 
Absorbance readings (OD600) were taken at regular time points. C. elegans hrg-4 was used as positive 
control and empty pFL61 vector acted as the negative control.  
 
  
List of oligonucleotides used for real-time PCR, gene cloning and dsRNA synthesis for 
Smhrg-1. 
 
Sequence (5’ – 3’) 
Forward Reverse 
Product 
Size (bp) 
Real-time PCR primers   
TGGTATCTTGGTTGGAGTATGCTT CCACACTCTCCAGTGTCCTC 148 
dsRNA Primers   
taatacgactcactatagggagaTTAGAGATG
TGGAAACTGCA 
taatacgactcactatagggagaGATACTAAC
TATGGCCTTTT 
381 
Cloning Primers   
gcggccgcATGTTATCTTCACCAT AAAAGGCCATAGTTAGgcggccgc 463 
Table 4.1. List of oligonucleotides used for real-time PCR, gene cloning and dsRNA synthesis 
for Smhrg-1. T7 RNA polymerase promoter sequence (in lower case) were added the forward and 
reverse dsRNA primers. NotI restriction enzyme recognition site (in lower case) were added to 
forward and reverse primers for cloning.   
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4.3 Results 
4.3.1 In silico analysis and molecular phylogenetic of S. mansoni putative haem transport 
protein (SmHRG-1) 
The S. mansoni putative haem responsive gene-1 (Smhrg-1, Smp_155760) is a 447-bp cDNA that is 
translated into a 148 amino acids protein. The predicted molecular mass (Mr) of the protein is 
approximately 16,944 Da. SmHRG-1 is found to share high similarity (74%) at the level of amino 
acid with an unknown protein in S. japonicum (AAW27489). Comparatively, similarity with 
homologous protein in zebrafish (NP_956300, similarity of 29%), human (NP_060312, 22%) and 
mouse (BAE23759, 22%) are significantly lower.  
 
SmHRG-1 was predicted to be a membrane-bound protein containing four helical transmembrane 
regions, with the predicted membrane topology and orientation shown in Figure 4.1. Sequence 
alignment of SmHRG-1 with homologous protein from C. elegans and zebrafish showed little 
sequence similarity and did not reveal any residues or domains conserved among these proteins. 
However, a conserved tyrosine (YXXxф) signalling motif (Rajagopal et al., 2008) was identified in 
both proteins from S. mansoni and S. japonicum (Figure 4.2). Tyrosine residues, which could serve 
as potential haem binding residues (Yuan et al., 2012), were noted in the second transmembrane 
domain and the region in the exoplasmic region between second and third transmembrane domain 
(Figure 4.2).  
 
Sequences from different organisms with sequence similarity to the C. elegans HRG-4 protein and 
which possess four predicted transmembrane domains, were used to construct a phylogenetic tree. 
Four clusters were indicated in the tree, mirroring the general phylogeny of the organisms that express 
the proteins (Figure 4.3). A sister relationship between the putative HRG-1s from S. mansoni, S. 
japonicum and Clonorchis sinensis is well supported by the bootstrap values. Two distinct clades 
were seen in the tree, with the trematodes and Protozoa forming one group and the nematodes and 
the vertebrates forming another. Although the bootstrap values (≥55) indicate good support for the 
groupings, it is unusual that the trematode sequences cluster with sequences from the Protozoa instead 
of clustering with that of the nematode. 
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Figure 4.2. Haem responsive gene-1 protein (HRG-1) sequences alignment. Multiple sequence 
alignment (Clustal Omega) of HRG-1 sequences of S. mansoni (GeneDB accession no.: Smp 
155760, SmHRG-1). Other sequences included C. elegans (Genbank accession no.:GAA55930, 
CeHRG4), zebrafish (NP 95630, DrHRG-1) and S. japonicum (AAW27489, SjHRG-1). Tyrosine 
signalling domain, YXXф (where Y is tyrosine, X is any other amino acid and ф denotes any 
amino acid with a hydrophobic side chain) is shown as the letter in blue. Histidine residue that 
constitutes the putative haem-binding residue is showed as the letters in red.  Sequences within the 
boxes labelled as TMD 1 – 4 are predicted transmembrane domain (TMD) of these proteins.  
 
Figure 4.1. Schematic diagram of the 
predicted membrane topology of SmHRG-1. 
Histidine residue that constitute the putative 
haem-binding residue are shown in the letter in 
red. A possible C-terminal tyrosine motif 
(YXXxф) is shown as the letters in blue (where 
Y is tyrosine, X is any other amino acid and ф 
denotes any amino acid with a hydrophobic side 
chain). 
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4.3.2 Tissue- and stage-specific expression of Smhrg-1 
Real time PCR (qPCR) of Smhrg-1 performed on all the life-cycle stages and on the three micro-
dissected tissues of S. mansoni are shown in Figure 4.4A and Figure 4.4B respectively. The highest 
relative abundance of Smhrg-1 transcripts occurred in the adult female worms, and specifically within 
the ovary. The lowest levels of Smhrg-1 transcripts were found in the cercarial stage, and in the 
gastrodermis of micro-dissected adult female tissues.  
4.3.3 dsRNA gene knock-down studies 
In the knock-down studies, the transcript level of Smhrg-1 was shown to decrease by approximately 
66.5% in adult schistosome worms treated with Smhrg-1 dsRNA as compared to the control worms 
(Figure 4.5A). A pulse chase experiment using Pd-mP was performed on the dsRNA treated worms.  
There was no significant difference between the two groups (Figure 4.5B). Worms treated with 
Smhrg-1 dsRNA showed decreased egg production (Figure 4.5C) and a delay in egg development 
(Figure 4.5D) compared with the control worms treated with luciferase dsRNA.  
4.3.4 Functional expression of Smhrg-1 in yeast mutant 
On the solid media, the Smhrg-1 and positive control Cehrg-4, demonstrate rescued growth at lower 
concentration of colony forming unit (CFU) and haem when compared with the negative control (cells 
transformed with empty pFL61 vector) (Figure 4.6). In the liquid media, the Smhrg-1 and Cehrg-4 
cells entered the log phase at ~24 hours ahead of the negative control, which entered log phase after 
~33 hours (Figure 4.7).  
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Figure 4.3. Phylogentic tree of HRG-1. Minimum evolution phylogenetic tree from amino acid 
sequences of homologous putative HRG-1 proteins from a variety of organisms. Published 
accession numbers and species name are shown for each sequence. Bootstrap values (1000 
resamplings) are shown to the left of the relevant nodes. General phylogeny of clusters is shown to 
the right of the nodes. 
 
Figure 4.4. Real time PCR (qPCR) of Smhrg-1.  A) qPCR of Smhrg-1 in different S. mansoni 
life-cycle stages.  B) qPCR of Smhrg-1 in different micro-dissected tissues of S. mansoni. Mira, 
miracidia; T.sporo, mechanically transformed sporocysts; Cerc, cercariae; 4NSomu; mechanically 
transformed schistosomula cultured for 4 days in the absence of RBCs; 4RSomu, mechanically 
transformed schistosomula cultured for 4 days in the presence of RBCs. Error bars represent the 
standard error of means (n=3). 
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Figure 4.5. dsRNA gene knock-down studies. (A) Gene expression of Smhrg-1 in S. mansoni 
worm pairs electroporated with the dsRNA Smhrg-1 compared with control (worm treated with 
luciferase dsRNA). Percentage inhibition of gene inhibition is shown with arrow above. (B) Pulse 
chase experiment performed on worms treated with dsRNA, showing the intensity of ovary after 
treatment. (C) Egg production of dsRNA treated worm pairs after 72 hours incubation. * p < 0.05 
(0.025) (two-tailed Student’s t-test) (D) Classification of the development stages of the eggs 
produced by dsRNA treated worms. Error bars represent the standard error of means. For (A) and 
(D), n=3. 
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Figure 4.6. Haem complementation assays of yeast cells on solid phase media.   Growth of 
serially diluted cells after 5 days at 30oC. The genes (left) inserted are as shown. pFL61, empty 
pFL61 vector; Cehrg-4, C. elegans hrg-4 gene; Smhrg-1, S. mansoni haem responsive gene-1. The 
cells were transformed on HEM1∆ deficient yeast cells on synthetic derived media containing 6% 
glycerol and 0.2% dextrose supplemented with 10, 1.0, 0.25 or 0.1 µM haemin.  
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Figure 4.7. Haem complementation assays of yeast cells on liquid culture.           
Transformed cells growth in liquid culture containing 1 µM haemin. Cells were cultured with 
shaking for 48 hours at 30oC and absorbance (OD600) measured at intervals. Both C. elegans 
hrg-1 and Smhrg-1 cells entered log phase at 24 hours, ahead of the empty vector control 
(pFL61). pFL61 cells only entered log phase after 33 hours. ** p < 0.01 (hrg-4 = 0.0015; 
Smhrg-1 < 0.0001) *** p < 0.0005 (< 0.0001) (two-way ANOVA). Error bars represent the 
standard error of means (n=3).  
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4.4 Discussion 
In the previous chapter, I demonstrated the uptake of exogenous haem in schistosomes, thereby 
supporting the study by Foster and Bogitsh (1986). However, the underlying mechanism facilitating 
this uptake in schistosomes remained unknown. In the current chapter I have identified and partially 
characterized the S. mansoni haem responsive gene-1 protein (SmHRG-1) that shares loose homology 
with the C. elegans haem transporter protein, HRG-4.  
Smhrg-1 transcripts were detected in all of the life-cycle stages investigated. Expression of SmHRG-
1 appears to be positively regulated by the presence of haem and RBCs. This can be seen from the 
high level of Smhrg-1 gene transcripts in all parasitic stages, which include the adult female and male 
worm, sporocyst stage and schistosomulum cultured in the presence of RBC. For all these stages, 
haem, as a component of haemoglobin, is in abundance in the parasitized host, the definitive 
vertebrate host and the intermediate Biomphalaria glabrata snail (Lee and Cheng, 1972b). 
Furthermore, it was seen that significant up-regulation of Smhrg-1 transcription occurred in 
mechanically transformed schistosomula that were cultured in the presence of RBCs compared with 
those cultured in medium alone. Interestingly, high level of Smhrg-1 transcripts was also found in 
the miracidial stage, a free-living stage that is unlikely to encounter haemoglobin. While it is possible 
that this up-regulation of Smhrg-1 transcript in the miracidium is related to the acquisition of 
exogenous haem by the sporocyst, the next life-cycle stage in schistosome, more information is 
required to explain this observation. It will be useful to investigate if this high gene transcripts 
correlates with high protein expression of SmHRG-1 in the miracidium and whether the use of 
immunohistochemistry and whole mount in-situ hybridization (WISH) will reveal the distribution of 
this gene and protein in miracidium. 
By qPCR of microdissected tissues, the highest relative abundance of Smhrg-1 transcripts was seen 
in the ovary, compared with vitelline glands and gastrodermis. Interestingly, the apparent abundance 
of SmHRG-1 is seen in an organ that strongly absorbed the fluorescent haem analogue, Pd-mP 
(Chapter 3; Figure 3), suggesting a correlation between abundance of this putative haem transporter 
and abundant haem uptake. Overall, results from the qPCR implicate the involvement of SmHRG-1 
in mediating the uptake of haem in tissues of S. mansoni. While the transcript level of Smhrg-1 in the 
adult female is likely to correspond to the level in the microdissected tissues, this relationship is likely 
to be relative instead of absolute. This is due to the difference in the preparation of the worms and 
tissue sections (Nawaratna et al., 2011a) prior to cDNA synthesis which may the RNA quality 
(Kerman et al., 2006) and thus, the subsequent cDNA synthesis. As such, it will be useful to have 
microdissected tissue of the adult males or other juvenile stages as a point of comparison.     
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Protein structure prediction of SmHRG-1 showed that the presence of four transmembrane domains, 
a conformation shared with HRG-1 proteins of C. elegans and Leishmania amazonesis (Huynh et al., 
2012; Rajagopal et al., 2008). Sequence alignment of SmHRG-1 did not reveal any domains or 
specific haem or iron-binding residues conserved among the homologous protein in S. japonicum, C. 
elegans and zebrafish. This is not surprising, given the low amino acid similarity (20-30%) among 
the HRG-1 protein (Khan and Quigley, 2013). The protein sequences of SmHRG-1 revealed the 
presence of a tyrosine signalling domain at the C-terminus of the protein (Figure 4.1 and 4.2). 
Interestingly, this domain was also found in C. elegans HRG-1, which appears to be a haem sensing 
(Rajagopal et al., 2008) as well as an transporter protein (Yanatori et al., 2010).  
A major feature of HRG proteins is the presence of a histidine residue, which is believed to be 
important for binding of the haem molecule (Huynh et al., 2012; Rajagopal et al., 2008).  This residue 
has been reported as occurring in the second TMD of CeHRG1 (Rajagopal et al., 2008), or in the 
second exoplasmic loop of Leishmania LHR1 and CeHRG-4 proteins (Huynh et al., 2012). It is 
surprising that a putative haem-binding residue should lie with the transmembrane region of the 
proteins, as appears to be the case with CeHRG1. While SmHRG-1 shared the characteristic four 
putative transmembrane domains (Huynh et al., 2012; Rajagopal et al., 2008) and also served as a 
haem transporter, it appears to lack the histidine residues, either within the membrane or in the second 
extracellular loop (Huynh et al., 2012; Rajagopal et al., 2008). However, it has been suggested that 
in CeHRG-4, the tyrosine residue in the second TMD may also serve as a potential haem-binding 
residue (Yuan et al., 2012). Thus, tyrosine residues that have been noted in the second TMD and 
second exoplasmic loop of the S. mansoni HRG-1 protein may be also be involved in the binding of 
haem during its uptake. 
A phylogenetic analysis of HRG family members revealed that the sequences of trematode proteins 
appear to cluster with the protozoan proteins while the mammalian proteins cluster with the proteins 
of nematodes. This clustering of related proteins could suggest that the proteins may have evolved as 
an adaptation to their way of nutrient acquisition. The top cluster includes the trematodes and some 
parasitic protozoans.  The only known protozoan sequences are from those that are intracellular 
parasites of immune cells or of the circulatory system, many of which will contain high levels of 
haem.  The similarity between schistosome HRG members and those of the parasitic protozoans may 
indicate some degree of convergent evolution, as the parasites evolved in association with the 
presence of high concentration of exogenous haem and haemoproteins. The HRGs from nematodes 
and mammals are from animals that are either not parasitic or they harbour obligatory symbiotic 
endobacteria, such as E. coli and Wolbachia species, that support the haem needs in these worms. It 
is recognised, however, that a shortcoming of this phylogenetic reconstruction of HRGs (Figure 4.3) 
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is the lack of HRG family members from other organisms, including those of the arthropods, and 
particularly the blood-feeding insects and arachnids, as well as from basal animals including 
Trichoplax, the sponges and ctenophores.  Although genomes for some of these organisms have been 
described, the low sequence identity among SLC48A family members (Khan and Quigley, 2013) 
requires detailed and exhaustive searches to identify other members.    This problem could be 
circumvented using bioinformatics to identify homologous sequence based on conserved residues and 
domains or protein structure. Hopefully, this will help to construct a more robust phylogenetic tree 
based on these conserved domains or protein structure (Marti-Renom et al., 2000) shared among the 
proteins and this could help to verify the above postulation.  
In my dsRNA knock-out study of Smhrg-1, I observed strong suppression, ranging from 54.6-86.1% 
decrease, of the Smhrg-1transcript compared to the Luciferase dsRNA-treated control worms (Figure 
4.5). Despite this, the pulse-chase experiment performed on these suppressed worms did not show 
any significant difference in the uptake and accumulation of Pd-mP between the two treatment 
groups. The absence of the expected phenotypic response, may be due to biological issues, such the 
long half-life of the target protein, as has been observed in RNAi studies of other schistosome proteins 
(Correnti et al., 2005; Manzano-Roman et al., 2012). A limitation of this investigation, then, is the 
absence of a means of detecting translated product in this study, using either Western blot analysis or 
immunolocalization (Geldhof et al., 2007; Manzano-Roman et al., 2012). A specific antibody against 
SmHRG-1 was not available in the current study, due to time constraints.  In addition, I also 
considered the possibility that the use of electroporation to introduce dsRNA makes the treated worms 
less suitable for functional analysis as suggested by others (Geldhof et al., 2007).  There may be 
problems due to the combined effect of electroporation and incubation of worms with Pd-mP, which 
may be ultimately damaging to the worms. This can be verified by performing a pulse-chase 
experiment on worm electroporated without any dsRNA. It is likely that there will be a decrease in 
the uptake and accumulation of Pd-mP in the electroporated worms. Some interesting effects related 
to transcriptional suppression of Smhrg-1 I did observe, however, is a decrease in egg production and 
a delay in the maturation of the eggs, suggesting that SmHRG-1 contributes indirectly to egg 
production and formation, through provision of haem. As can be seen from figure 4.5D, there appears 
to have three worm pairs with egg count that are significantly higher than the others in the control 
treatment. While it can argued that these worm pairs are outlier in the result and should be excluded. 
However, I did not observe any no obvious experimental error occurring during the study and thus, I 
do not see the need to exclude these data. Instead, I would suggest future experiments using worms 
fed with dsRNA as this procedure is likely to be less than damaging than electroporation despite being 
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less efficient (Geldhof et al., 2007). This will add to data of the effect of Smhrg-1 knock-down on 
schistosomes.  
In the initial haem complementation assays, there was no difference in growth rate for all mutant 
yeast strain when cultured in the standard SD minus media (0.67% (W/V) dextrose) regardless of the 
concentration of haemin used. As such, I hypothesized that the loss of haem biosynthetic capabilities 
causes the HEM1Δ yeast strain to ferment glucose under anaerobic condition. Thus, the uptake of 
haem mediated by SmHRG-1 and C. elegans HRG-4 proteins may be detrimental to the cells and 
resulted in slower cell growth. In order to circumvent this problem, I switched to SD minus medium 
containing using 2% (V/V) glycerol and 0.2% (W/V) dextrose.  Using the glycerol-dextrose based 
medium, I have managed to demonstrate in both solid and liquid media that the Smhrg-1 functionally 
rescued the mutant HEM1Δ yeast cells in a low haem environment. This indicates that SmHRG-1 
promotes the uptake of haem in the defective HEM1Δ yeast strain.   
Overall, the results of Chapter 4 present SmHRG-1 as a potential haem transporter protein for S. 
mansoni. As the main source of pathology in schistosomiasis occurs as a result of the immune 
response against the eggs lodged in various tissues and organs (Chuah et al., 2014), the disruption of 
egg production in schistosomes is likely to be an effective strategy against disease pathology and 
transmission (You et al., 2012). As such, the involvement of SmHRG-1 in egg production and 
subsequent maturation of egg is evidential that it may represent a promising target for drug and 
vaccine development in the control of this disease.   
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Chapter 5 – Conclusions and future directions 
Blood is a comprehensive nutrient-rich medium that supports the growth, development and 
reproduction of many parasites (Whitfield, 1979). As the largest cellular component of blood, the red 
blood cell (RBC) is an essential constituent of the diet of all haematophagus organisms (Bogitsh and 
Carter, 1977; Cheever and Weller, 1958; Whitfield, 1979). It has been estimated that paired adults of 
Schistosoma mansoni process approximately 330,000 cells per hour (Lawrence, 1973). Adult 
females, which have higher nutrient requirements in order to support egg production, can ingest up 
to 13 times as many RBCs as males (Lawrence, 1973). Schistosomes have a well-ordered enzymatic 
cascade that digests and releases the contents and components of red cells to liberate free amino acids 
and dipeptides from host haemoglobin for absorption across the gastrodermal lining (Brindley et al., 
1997; Caffrey et al., 2004). Although it has been demonstrated that RBCs contribute significantly to 
the amino acids requirement of schistosomes (Timms and Bueding, 1959; Zussman et al., 1970), there 
is limited information on whether other components of RBCs are equally important to parasite 
nutrition. 
As the reactive core of haemoglobin, haem is one of the most abundant biomolecules released from 
the catabolism of host erythrocytes (Egan, 2008; Oliveira et al., 2000a; Whitfield, 1979). Haem is an 
iron-containing tetrapyrrole, a molecule capable of interacting with DNA, lipid and protein and 
generating free radicals (Ponka, 1999; Toh et al., 2010). Despite its potential as a toxic pro-oxidant, 
haem is indeed indispensable in a wide range of biological reactions, including those associated with 
electron transfer and redox chemistry (Ponka, 1999; Toh et al., 2010). While the biological 
importance of haem for schistosomes is still not clear, the demonstrated presence of haemoproteins, 
like cytochrome b and cytochrome oxidase (Coles, 1973; Glanfield et al., 2010; Liu et al., 2006; 
Saeed et al., 2002), indicates an innate need in parasites for this molecule.  
De novo biosynthesis of haem involves highly conserved pathways consisting of eight or nine 
enzymes (Heinemann et al., 2008). For schistosomes and other blood feeding parasites, the abundance 
of exogenous haem from RBC degradation could render the existence of an endogenous haem 
biosynthetic pathway in these parasites a redundancy (Cain, 1969; Chang et al., 1975; Ohagan, 1974). 
In many studies, it has been suggested that haematophagy leads to a gradual evolutionary loss of de 
novo haem biosynthesis in these parasites. This phenomena can be seen by the absence of any haem 
biosynthetic activity in Rhipicephalus microplus (Braz et al., 1999) and partial loss of haem 
biosynthetic ability in Leishmania species (Chang et al., 1975) and Brugia malayi (Wu et al., 2009). 
Even for malaria, it was found that parasite enzymes account for approximately 20% of total haem 
biosynthetic activity, with host enzymes required for the bulk of this activity (Bonday et al., 1997). 
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Not all haematophagous parasites appear to have lost their ability to make haem.  In the hemipteran 
Rhodnius prolixus, it was demonstrated that this parasite possess a fully functional haem biosynthetic 
pathway (Braz et al., 2001; Braz et al., 1999). Overall, multiple strategies have been employed to 
investigate the haem biosynthetic capabilities by different parasite groups.    
It has been proposed that S. mansoni is incapable of de novo haem biosynthesis based on lack of 
enzymatic activities in worm extracts (Rao et al., 2005).  However, all eight enzymes of the haem 
biosynthetic pathway have been identified in the expressed sequence tag (EST) databases of S. 
mansoni and S. japonicum (Berriman et al., 2009; Glanfield et al., 2007; Liu et al., 2006). These 
contradicting reports illustrated the current knowledge gap in the metabolism of haem in 
schistosomes. In this study, I characterized two putative schistosome haem biosynthetic enzymes, 
aminolevulinic acid dehydratase (ALAD) and ferrochelatase (FC).  
In my study, I noted high levels of Sm-alad and Sm-fc gene transcripts in adult females (Chapter 2, 
section 2.3.3). In the adult R. prolixus females, it has been demonstrated that haem biosynthesis was 
fundamental to vitellogenesis (Braz et al., 2001; Machado et al., 1998; Walter-Nuno et al., 2013), 
and it is reasonable, therefore to hypothesise that haem biosynthesis is essential in supporting 
reproductive activity in female schistosomes, and notably vitellogenesis. While in silico analysis of 
these two schistosome proteins indicates that they are active enzymes (section 2.3.1), 
complementation and enzymatic assays were inconclusive as to whether the enzymes had a role in 
haem synthesis (section 2.3.4 and 2.3.5). Another possible reason for the lack of activity of these 
proteins could be that these enzymes may be multifunctional (Greenbaum et al., 2003; Guo et al., 
1994).  
As the schistosome haem biosynthetic enzymes share high amino acid identity with the human 
homologues, they are unlikely to serve as useful anti-schistosomal targets. However, inhibition of 
haem biosynthetic enzymes of malaria and of the obligate Wolbachia endosymbiont of Brugia malayi 
in vivo is detrimental to the survival of the parasites (Nagaraj et al., 2013; Wu et al., 2009).  If 
conformational differences in the structures of human and schistosome haem biosynthetic enzymes 
can be identified, the pathway may be targetable in drug design.  
The schistosome gastrodermis is the primary site for the digestion of host red cells (Morris, 1968).  
Catabolism of the cells releases essential nutrients, such as amino acids, lipids and haem that are used 
by the parasite to support synthesis of parasite biomolecules and membranes. Ultrastructural studies 
have shown periodic irregular projections and micropinocytic depressions on the gastrodermis 
surface (Morris, 1968; Spence and Silk, 1970).  Furthermore, microarray gene expression analysis of 
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micro-dissected gastrodermis has identified many molecules associated with nutrient uptake 
(Nawaratna et al., 2011b), reflecting the absorptive nature of this tissue. Despite these observations, 
information on pathways associated with the uptake of nutrients in the gastrodermis is limited. As 
haem has been viewed as a toxic waste product of RBC catabolism detrimental to survival of 
schistosomes and other haematophagous parasites, intensive research have been done on the 
formation of haemozoin in these parasites (Egan, 2008; Oliveira et al., 2000a; Oliveira et al., 2000b). 
Despite an early report showing the presence of haem uptake system in schistosomes (Foster and 
Bogitsh, 1986), the nutritional role of exogenous haem in schistosomes has been a largely neglected 
field. It was the goal of this project to address the deficiency in knowledge on haem metabolism in 
schistosomes and to identify and characterize mechanism facilitating the exploitation of host haem to 
support normal development in the parasites. 
Uptake of exogenous haem by schistosomes was first reported by Foster and Bogitsh, who observed 
that S. mansoni schistosomula fed with radiolabelled haemoglobin demonstrated incorporation of the 
labelled-haem moiety ([3H] or [14C] δ-aminolevulinic acid (ALA)) into both proteinaceous and non-
proteinaceous components of parasite extract. This is in contrast to leucine-labelled haemoglobin, 
which only showed radioactivity in the protein portion (Foster and Bogitsh, 1986). However, this 
study provided limited information on how salvaging of host haem contribute to the nutritional or 
developmental status of the parasites. It was anticipated that when similar work to that of Foster and 
Bogitsh was performed using other parasitic life-cycle stages of schistosomes, results would be 
comparable. In R. microplus, the intracellular transport of haem was demonstrated by pulse-chase 
experiment using the fluorescent haem analogue, palladium mesoporphyrin IX (Pd-mP) (Lara et al., 
2005). Using this method, I verified the presence of a haem uptake system in adult S. mansoni worms. 
Although the Pd-mP is structurally similar to that of haem, the replacement of the metal ion within 
the porphyrin from iron to palladium, led us to question if these two molecules possess varying 
biochemical properties. In a trial experiment with worms cultured in medium containing both haem 
and Pd-mP, a decrease in fluorescence intensity was noted only when concentration of haem was 
equal or higher than that of Pd-mP used (results not shown). This lent credibility of the use of Pd-mP 
as haem analogue in the pulse-chase experiment.  
In my pulse-chase experiments, bound Pd-mP was found to accumulate in the ovary and vitelline 
tissue of adult S. mansoni females (Chapter 3, section 3.3.2). This suggests that exogenous haem 
produced during blood-feeding is required for embryogenesis and vitellogenesis in schistosomes. 
Since all enzymes for de novo haem biosynthesis are present in adult schistosomes, it is possible that 
the parasites do synthesise haem. As all eight enzymes of the haem biosynthetic pathway have been 
identified in the S. mansoni EST databases, it appears likely that schistosomes are capable of de novo 
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haem biosynthesis. However, this contradicts the need for a system to salvage host haem.  
Interestingly, studies using R. prolixus provide evidence that these two systems are essential and 
complementary in supporting egg production (Braz et al., 2001; Machado et al., 1998; Walter-Nuno 
et al., 2013). In R. prolixus, the rate of haem biosynthesis increases in response to a blood meal (Braz 
et al., 2001). Similarly, S. mansoni schistosomula significantly up-regulate Sm-alad and Sm-fc in the 
presence of RBCs. This observation suggests that exogenous haem may have a regulatory role in 
endogenous haem biosynthesis in both R. prolixus and S. mansoni. It was recognized that haem is 
crucial for vitellogenesis and embryogenesis in many organisms, including Caenorhabditis elegans, 
zebrafish and R. prolixus (Braz et al., 2001; Chen et al., 2011; Rajagopal et al., 2008; Walter-Nuno 
et al., 2013). In R. prolixus, exogenous and endogenous haem was found to be equally essential for 
normal production of eggs (Braz et al., 2001; Machado et al., 1998). For the auxotroph C. elegans, 
exogenous haem plays an equally important part in the normal development of the growing oocytes 
(Chen et al., 2011). From my study and these past observations in other organisms, I conclude that 
the salvaging of host haem is likely an important aspect in maintaining normal reproductive function 
in schistosomes.  
In order for exogenous haem to be used effectively, the presence of a receptor or transporter is 
required to facilitate transmembrane transport (Light and Olson, 1990; Shayeghi et al., 2005). The 
haem acquisition system in bacteria has been extensively researched (Benson and Rivera, 2013). In 
bacteria, unique surface receptor proteins mediate the scavenging of host haem through the binding 
to haem or haemophores (Benson and Rivera, 2013). A similar system of haem-binding proteins for 
the acquisition of haem, in association with surface receptor protein was also found in R. prolixus and 
many haematophagous insects (Donohue et al., 2009; Gudderra et al., 2001). Two molecules, haem 
responsive gene-1 (HRG-1) and haem responsive gene-4 (HRG-4) were first identified as potential 
haem transporter proteins in C. elegans, as they were found to be transcriptionally regulated by haem 
deficiency and their encoded proteins shared similarity with high-affinity permease transporters 
belonging to the SLC48A1 family of solute carriers (Rajagopal et al., 2008). Transcriptional 
suppression of hrg-1 and hrg-4 confirmed the involvement of the expressed proteins in haem uptake 
and homeostasis in C. elegans (Rajagopal et al., 2008). Subsequently, HRG-1 or SLC48A1 orthologs 
were discovered in zebrafish, human and Leishmania amazonesis. Characterization of HRG’s in these 
organisms further verifies the functionality of their proteins as haem transporter proteins (Huynh et 
al., 2012; Rajagopal et al., 2008; Yanatori et al., 2010). Using an approach similar to these earlier 
studies, I identified the putative S. mansoni haem responsive gene-1 protein (SmHRG-1) based on 
loose homology with the C. elegans haem transporter protein, HRG-1 and HRG-4. In my studies, the 
transcription of Smhrg-1 was positively regulated by the presence of RBC and haem in the life-cycle 
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stages investigated (Chapter 4, section 4.3.2). The highest level of Smhrg-1 transcripts was noted in 
the micro-dissected ovarian tissues of adult female S. mansoni, which correlated with the observed 
uptake and accumulation of Pd-mP in the ovary during the pulse-chase experiments (Chapter 3, 
section 4.3.2). Further, I demonstrated the ability of SmHRG-1 to promote uptake of haem in the 
defective HEM1Δ yeast strain and thereby, rescued growth in a low haem environment (section 
4.3.4). These findings identified SmHRG-1 as a potential transporter protein involved in the uptake 
of haem to the ovary of schistosomes.  
Although it is understood that dietary haem serves as an important source of iron in humans, the exact 
mechanism mediating this absorption in the intestines still remains to be resolved. Other than the 
HRG-1 protein, the haem carrier protein (HCP1) has also been identified as a candidate intestinal 
haem transporter (Shayeghi et al., 2005). It has been shown that human HRG-1 localizes to the 
basolateral membrane of enterocytes and lysosome and binds to haem more efficiently at a low pH 
(O'Callaghan et al., 2010; Yanatori et al., 2010).   HCP1 localizes to the apical membrane, leading to 
the hypothesis that the protein is involved in intestinal uptake of haem (Shayeghi et al., 2005). In 
addition, HRG-1 function as a transporter facilitating the transport of haem from lysosomes into the 
cytosol has also been proposed (Yanatori et al., 2010). Unlike the mammalian intestine, the 
schistosome gastrodermis environment is highly acidic in order to aid haemoglobin digestion 
(Brindley et al., 1997). In order to mediate the absorption of haem in such an environment, HRG-1 
will be a better candidate transporter protein than HCP1. Further, no homologs to the human HCP1 
have been identified for S. mansoni and S. japonicum. Thus, unlike the mammalian system, the uptake 
of haem in schistosomes may be primarily facilitated by SmHRG-1.  However, this requires further 
research, which unfortunately was beyond the time available for my PhD study.  
An anti-schistosome effect of cyclosporin A (CsA) was first reported by Bueding et al. (1981), and 
verified in subsequent studies (Bout et al., 1984; Kasinathan et al., 2011; Munro and McLaren, 1990). 
As CsA is an immunosuppressant, its use clinically for the prevention and treatment of 
schistosomiasis is not recommended (Pons et al., 1988). Thus, defining the specific schistosome 
molecule(s) targeted by CsA to produce the anti-schistosome effect is essential to optimize the 
therapeutic potential of this drug. As CsA was found to disrupt egg production in schistosomes 
(Kasinathan et al., 2011), I hypothesized that the compound may target the uptake of haem by the 
ovary. In my study in Chapter 3, I found that treatment of adult worms with CsA inhibited the uptake 
of Pd-mP to the ovary in a concentration-dependent manner (section 3.3.3). In addition, I also found 
that CsA disrupted egg production and delayed maturation of eggs in schistosomes (section 3.3.3), 
though this effect was not found to be concentration-dependent. Although SmHRG-1 and proteins 
belonging to the solute carrier family 48, member 1 (SLC48A) are not known targets of CsA, my 
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results implicate the involvement of SmHRG-1 in haem uptake in schistosomes and the susceptibility 
of SmHRG-1 to this compound. As such, it is important to verify if SmHRG-1 is the primary target 
of CsA in the inhibition of haem uptake in the ovary. In order to do this, the relationship of SmHRG-
1 and CsA has to be scrutinized from different angles. One part of the investigation will be to 
determine if antibodies against SmHRG-1 inhibit the uptake and accumulation of haem in 
schistosomes. Another aspect will be to examine if CsA have any affinity for SmHRG-1 proteins and 
whether treatment of cells over-expressing SmHRG-1 with CsA leads to decrease in haem uptake in 
these cells.  
The result from this study certainly provides foundational information on the importance of haem in 
the nutritional needs of schistosomes and the involvement of a transporter protein, SmHRG-1, in the 
transmembrane uptake of haem in schistosomes. However, more needs to done to have a better 
understanding of this haem uptake and homeostatic mechanisms in schistosomes. Future work may 
look at the involvement of haem-binding protein in schistosomes in the transmembrane transport of 
haem. As studies done in haematophagus ticks have demonstrated that haem-binding proteins are 
essential in protecting against the toxic effect of haem as well as mediating the transport and uptake 
of haem (Gudderra et al., 2001; Gudderra et al., 2002), thus haem-binding proteins are likely to have 
equally important roles in schistosomes. Furthermore, my results also showed that Pd-mP found in 
the ovaries and vitelocytes are protein-bound. This can be done by culturing the worms with 
radiolabeled haem before extracting protein component from the parasite. The protein extract can be 
put through protein gel electrophoresis to identify proteins with potential haem-binding ability. These 
proteins can then be analysed using mass-spectrometry and sequences can be compared against 
annotated proteins in other organisms.  Certainly, the involvement of other transporter protein, like 
the ABC transporter, cannot be excluded in their importance in mediating the uptake and 
transmembrane transport of haem in schistosomes. This can be seen by the recent work by Korolnek 
and colleagues (2014) showing that a conserved multidrug resistance (MDR) protein are involved in 
regulating the systemic haem homeostasis in C. elegans. In my study, the comparatively low 
transcript level of Smhrg-1 in the microdissected gut tissues and the lack of correlation of the 
phenotypes between the worms treated with CsA and Smhrg-1 dsRNA are suggestive of the 
involvement of other transporters proteins in the mediating haem haemostasis and uptake in 
schistosomes. While it may worthwhile to investigate if MDR proteins are potential haem 
transporters, it should be noted that MDR are involved in a wide range of physiological function in 
regulating normal cellular functions (Kasinathan et al., 2011). Also, at least seven potential MDR 
proteins have been identified in the S. mansoni genome database (Logan-Klumpler et al., 2011). This 
will further complicates haem uptake studies in schistosomes involving MDR proteins. Another 
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suggestion for future work will be to perform gene silencing of Smhrg-1 in mechanically transformed 
schistosomula. This is because as the developing parasitic stage of schistosome in the vertebrate host, 
gene transcription and protein expression are high. As such, they are likely to be more sensitive to 
the RNAi treatment and thus, provide obvious outcome on how the knockdown of Smhrg-1 affects 
the worms.    
I have shown that the uptake of exogenous haem in schistosomes is required in the parasite egg 
production process and identified a potential haem transporter protein, SmHRG-1. As the main 
pathology in schistosomiasis occurs as a result of the immune response against the eggs lodged in 
various tissues and organs (Chuah et al., 2014), the disruption of egg production in schistosomes is 
likely to be an effective strategy to reduce disease pathology and transmission. For this, we need 
better understanding of the schistosome reproductive biology (Cogswell et al., 2012). Thus, SmHRG-
1 may represent a promising target for drug and vaccine development in the control of this disease, 
given its involvement in egg production and subsequent maturation of egg.   
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Appendix 1 – Nucleotide and protein sequences 
>Sm-alad 
ATGAATTCTACTCATCCCCTCCATTCATCATACTCAAATTTGTTGTTCAGACAGTGGCA
AACTGCAAACTATAAGGTCAGTGCCGAGAATCTTGTGTATCCAATTTTCCTCAGGTATA
TTATATTGTTTTCTCATTCATTTAGCCAAGACCCAGATTGTGATAAAATAATTACTAGC
CTAATAGACCAACGTCGAATAGGATGCAACCGAATCATCGAGTTCTTAACACCTTTGG
TGGCCAAGCAACTAAAATCTGTATTGTTGTTTGGGACAATCAGTAAAGACCAAAAAGA
TGCTACAGGATCAGCTTGTGATACACCAAATTCACCAGTCATTCAGGCAATCAAGTTGC
TGAAGTCAAAATTTCCGGATTTAATAGTGATTTGTGATGTTTGTTTGTGTGCATACACT
GACAGTGGTCATTGTGGTATTTTACGTGATGACGGCTGCCTTGACGTACCTAGAACTCT
TGAACGTTTAGCGGAAATATCTAAACGATTTGCCCTAGAAGGAGCTGATGTTATTGCCC
CTTCTGACATGATGGATGGACGTGTGAAAAAAATCAAGATGGCTATAGAGAGTATCGG
TCTCAGTGGGAAAGTAGCCGTTATGTCTTATTCAGCCAAATTTGCATCTTGTTTGTACG
GTCCTTTCAGAGATGCTGCTCAATCTGCACCTTCTTTTGGAGACCGTCGGCATTACCAG
CTTCCTCCTGGTGCCAAAGGATTGGCTCTACGTGCTGCTATTCGCGATGCGAACGAAGG
AGCTGACTTCATAATGGTAAAACCTGGTCTTCCTTATCTGGATATTGTGAATGAGCTAC
GACAGTTGCTACCTCATCATCCTCTAGCAGTTTATCATGTTTCTGGTGAATATGCAATG
CTAAAACATGCCGCAAATGCTGGGGCTATCGATTTAAAGCAAGCCGCCTTAGAATTGA
TGACTGCATTCCGTCGTGCCGGTAAATTTGCATACCAGACAATGTTTGCTTATGCTTAA 
>SmALAD  
 
MNSTHPLHSSYSNLLFRQWQTANYKVSAENLVYPIFLRYIILFSHSFSQDPDCDKIITSLIDQ
RRIGCNRIIEFLTPLVAKQLKSVLLFGTISKDQKDATGSACDTPNSPVIQAIKLLKSKFPDLIVI
CDVCLCAYTDSGHCGILRDDGCLDVPRTLERLAEISKRFALEGADVIAPSDMMDGRVKKIK
MAIESIGLSGKVAVMSYSAKFASCLYGPFRDAAQSAPSFGDRRHYQLPPGAKGLALRAAIR
DANEGADFIMVKPGLPYLDIVNELRQLLPHHPLAVYHVSGEYAMLKHAANAGAIDLKQA
ALELMTAFRRAGKFAYQTMFAYA* 
>Sm-fc 
ATGTTTGCGTTGCGTGGGCATTTGCGTTACTACTTTGGTAATCGTTACTGTGTGCATAAT
CGACAATGCTCGCAAAAAGCGAAAACTGGCATAATGTTGCTAAACATGGGTGGCCCGG
AAACTACAAAGGAAGTACAAAATTTTTTAACACGTCTATTCTCTGACAAAGAAATTAT
CCGTATGCCGTTCCAAGATCTTTTAGCTCGTTTCGTAGCATGGAGAAGGTCGCCTAAGA
TCGAGAAACAGTATTCTCATATTGGTGGTGGGTCTCCAATTCTATATTGGACCAAAGTA
CAGGGTGAAATGATGATAAAACACTTAGATGCTATTAGCCCAGAAACAGCTCCTCATA
GATTCTACGTTGCATTTCGTTATGTCCATCCTCTTGTAGAATCTTGTGTTAATGAAATAG
AAAGAGACGGCGTAGAGCGTGTTGTTGCTTTTAGTCAGTATCCACAATACAGCTGTACT
ACTTCGGGAAGCAGCTTAAATACCGTTGTTCGTCATTACGAAAGTGAAGAAAAAAATT
TCAATGGGGTGGAAAGTATTGAGCTTCCTTCCGTACAGAACAATAGACCTGGACCGAT
CTGGTCCTTTATTGACAGATGGCCTGTTTTCCCCCCGCTAATTGACAGTTTTGCCAGTAA
AATTCGTGATGAGCTCCAGAGTATTGAGGATGAAACAGAGCGTGCGAACACCGTCCTA
ATTTTCAGTGCACACTCGATTCCATTATCTGTCGTCAATCGCGGTGATCCTTATCCTCAG
GAAGTAGGTGCCACTGTTCACGCAATCATGAAACAACTCAATTTCTCGTGGCCTTATCG
TCTTACATGGCAATCTAAAGTTGGTCCAGCTGCTTGGTTAGGTCCATCAACAGAAGACA
CTCTATATGGGTTGAGTCGTTTGGGATATCGACATGCACTCTTAATTCCTGTCGCATTC
ACTCTAGATCATATAGAAACCCTTTATGAAATGGACATAGAATATTGCTCTGAAGTAG
CAGCCAAAGCCGGTATGGTTTCTGTACGCAGATCACAATCACTGAATGGTGACCCTGC
ATTCGGTCAAGGCCTAGCCGAATTAGTCCTAGATCATCTTCGTCGGGGTGATCCATGCT
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CGAAACAGTTCATGCTTCGCTGTCCAATGTGTACTAACCCATCTTGTGAACGTACCAGG
AAGTTCATTATGGCCCAAAAAGAACAAGTACGTGACTGGACAACTCTGCACTTGTCAA
ACAGTGAGTATGTACGTTGA 
>SmFC 
 
MFALRGHLRYYFGNRYCVHNRQCSQKAKTGIMLLNMGGPETTKEVQNFLTRLFSDKEIIR
MPFQDLLARFVAWRRSPKIEKQYSHIGGGSPILYWTKVQGEMMIKHLDAISPETAPHRFYV
AFRYVHPLVESCVNEIERDGVERVVAFSQYPQYSCTTSGSSLNTVVRHYESEEKNFNGVESI
ELPSVQNNRPGPIWSFIDRWPVFPPLIDSFASKIRDELQSIEDETERANTVLIFSAHSIPLSVVN
RGDPYPQEVGATVHAIMKQLNFSWPYRLTWQSKVGPAAWLGPSTEDTLYGLSRLGYRHA
LLIPVAFTLDHIETLYEMDIEYCSEVAAKAGMVSVRRSQSLNGDPAFGQGLAELVLDHLRR
GDPCSKQFMLRCPMCTNPSCERTRKFIMAQKEQVRDWTTLHLSNSEYVR* 
 
>Cehrg-4 
ATGACTGCTGAAAATCGAGGATTCTGTCAACTGATTTGTCATATAAACGTTCGAATTGG
ATGGACAATATTTGGAATTGTTTTTGGAATATCTGCAATTTTAACATATGCAATCAAAT
TTCATAATTGGTCAGCCACAGCAACAACTGCTATTGCTACACTTTTTGCGTGTGAAACA
TTGTATTTGTATTGGGCTTTGAAGAAAAATACAATTGTTAACTGGAAGAGTAGTACTTT
TCAGTTGATGATATGGCCAAACGTATTTATTGGTCTTCTCGGACTTCTCGGCTGCCTTGT
TTGCTACATTATTGCAGGAATCACTCATCAGGGTGCAGGATCTATCCAAGCAATGTATG
GAGAGAATCTTTGGTTTACTGGATCATGGAGTCTTGTGATCACTAAATGGACTTGGCAA
AATGCATTCTTTGCCAGAAAATACCTCAACAAAATTGGAACAGCTTCCGAAGATGGAG
ACATTGATGATGACGATGTTGAAGTCATTAAAAGTTAA 
>CeHRG-4 
MTAENRGFCQLICHINVRIGWTIFGIVFGISAILTYAIKFHNWSATATTAIATLFACETLYLY
WALKKNTIVNWKSSTFQLMIWPNVFIGLLGLLGCLVCYIIAGITHQGAGSIQAMYGENLWF
TGSWSLVITKWTWQNAFFARKYLNKIGTASEDGDIDDDDVEVIKS 
 
>Smhrg-1 
 
ATGTTATCTTCACCATTAGGATTTAATGTTCAACGAAATGTAAAGATAAAATCAGTTTA
CCAGGTTATTGGTATCTTGGTTGGAGTATGCTTCAATATATTTTATATCACAGTTAGAG
ATGTGGAAACTGCAGTTTGTTGCTCATTTTCAATTCTGTTTGGGTCTGTTGGATTATATG
TTGACATCCAGTTACTTAGAGGACACTGGAGAGTGTGGCCATATATCCTTCGACGGTAC
ATGTTGCTGGGTATAGTTGGGTCAGTTCTCTCTTCAGTAGTGCTTGTGGGGAATTTATA
CAATGAAATAAAATACCGCCAAATGTCATCCTTTCGGTCAGATTTATGGTCGTTGTCCT
CCCTACACTGGTCTGCTATCCTGGCATGGACATCTAGGAAGTACCATATCCTGCTAACA
GATGTTTATACGCTATCAAAAGGCCATAGTTAG  
 
>SmHRG-1 
 
MLSSPLGFNVQRNVKIKSVYQVIGILVGVCFNIFYITVRDVETAVCCSFSILFGSVGLYVDIQ
LLRGHWRVWPYILRRYMLLGIVGSVLSSVVLVGNLYNEIKYRQMSSFRSDLWSLSSLHWS
AILAWTSRKYHILLTDVYTLSKGHS* 
 
 
